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 Heme oxygenase-1 (HO-1) is a stress-inducible enzyme that catalyzes the rate-limiting 
step in the hemin degradation pathway. Studies in mammalian systems determined that HO-1 
promoted cell survival by reducing oxidative damage in cells exposed to heavy metal toxicants. 
While most of the knowledge regarding HO-1 synthesis and function was derived from 
mammals, less is known about this stress-inducible protein in poikilothermic vertebrates such as 
amphibians and fish. The aim of the present study is to investigate stress-induced accumulation 
of HO-1 and its potential cytoprotective effects in A6 kidney epithelial cells derived from the 
aquatic frog, Xenopus laevis. Treatment of A6 cells with hemin, baicalein (a plant flavinoid) or 
CdCl2 induced HO-1 accumulation in a concentration- and time-dependent manner. While CdCl2 
treatment also induced the accumulation of the heat shock proteins (HSPs), HSP70 and HSP30, 
their accumulation was not detectable in cells treated with baicalein or hemin. 
Immunocytochemical analysis revealed that hemin, baicalein and CdCl2 treatment induced the 
accumulation of HO-1 primarily in the perinuclear region in a granular pattern with some 
localization in the nucleus. While treatment of cells with 25 μM hemin or 200 μM baicalein 
induced slight disorganization of actin filaments, exposure of cells to higher concentrations of 
CdCl2 (e.g. 200 μM) produced pronounced actin cytoskeletal disorganization and membrane 
ruffling. Stress-induced accumulation of HO-1 was the result of de novo synthesis since 
upregulated HO-1 levels were inhibited by the transcriptional and translational inhibitors, 
actinomycin D and cycloheximide, respectively. Furthermore, the heat shock factor 1 (HSF1) 
inhibitor, KNK437, suppressed hemin-, baicalein-, and CdCl2-induced HO-1 accumulation. 
Since previous studies reported that stress-induced HO-1 accumulation may be associated with 
oxidative stress, the levels of the ROS-responsive transcription factor, Nrf2, were measured and 
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found to increase in cells treated with baicalein and CdCl2 but not with hemin. However, levels 
of the antioxidant enzyme, peroxiredoxin 5 (PRDX5), were elevated in response to all three 
stressors. Finally, analysis of reactive oxygen species (ROS) production using a fluorescent 
probe detected enhanced ROS amounts in A6 cells treated with baicalein and CdCl2 but not with 
hemin. In another approach, A6 cells, which were incubated with buthionine sulfoximine (BSO), 
an inhibitor of glutathione synthesis and a known inducer of ROS, enhanced HO1 accumulation 
in cells treated with CdCl2 but with either hemin or baicalein. This study also determined that 
HO-1 accumulation was required for cytoprotection of A6 cells to CdCl2 since cotreatment with 
the HO-1 enzyme activity inhibitors, tin protoporphyrin (SnPP) and zinc protoporphyrin (ZnPP), 
enhanced cadmium-induced actin cytoskeleton dysregulation and the formation of aggregated 
protein and aggresome-like structures. Finally, this study examined whether treatment of A6 cells 
with hemin or baicalein could ameliorate the toxic effects of 275 μM of CdCl2. Hemin and 
baicalein both inhibited the effect of cadmium on the dysregulation of actin cytoskeleton and the 
accumulation of aggregated protein and aggresome-like structures. Furthermore, this protective 
effect was suppressed with the addition of SnPP. In summary, this study has shown that HO-1 
accumulation may play a vital role in regulating the stress response against cadmium treatment in 
Xenopus laevis. Additionally, the present research has revealed, for the first time, that 
cotreatment of cells with low concentrations of either hemin or baicalein inhibited the formation 
of cadmium-induced aggregated protein and aggresome-like structures whereas cotreatment with 
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1.1 Heme oxygenase 
 Heme oxygenase was first described in 1968 after it was determined that the degradation 
of heme was an enzymatically-catalyzed process (Tenhunen et al., 1968). Heme oxygenase-1 
(HO-1), the stress inducible isozyme of heme oxygenase that catalyzes the first step of the heme 
degradation pathway (Müller et al., 1988). This enzyme is also known as heat shock protein 32 
(HSP32) given the discovery of an enhancer, the heat shock element (HSE), upstream of the 
coding region of the rat ho-1 gene as well as its induction by heat shock in a few but not all 
experimental systems (Müller et al., 1987; Taketani et al., 1988; Ryter and Choi, 2016). In 
addition to the stress-inducible HO-1, two constitutive heme oxygenase isozyme genes exist, 
namely, ho-2 and a pseudogene ho-3 (Lee et al., 1996; Platt and Nath, 1998; McCoubrey et al., 
1997; Hayashi et al 2004). HO-1, which acts as an oligomer, catalyzed the breakdown of heme 
into CO, free iron and biliverdin (Platt and Nath, 1998; Hwang et al., 2009). This process 
required the presence of NADPH and oxygen (Ortiz de Montellano, 2000). Biliverdin was then 
converted to bilirubin by biliverdin reductase whereas free iron was sequestered by the iron-
binding protein ferritin (Platt and Nath, 1998; Ferris et al., 199). Free iron was also removed 
from the cell by an iron-pumping ATPase, which was shown to co-localize with HO-1 (Ferris et 
al., 1999). While HO-1 is an ER protein, it lacks a signal peptide and a KDEL retention sequence 
(Gottlieb et al., 2012). However, HO-1 is posttranslationally inserted into the ER membrane via 
its C-terminal end (Yoshida and Sato, 1989). This was demonstrated using in vitro translated rat 
HO-1, which spontaneously inserted into microsomes in the absence of the signal recognition 
particle (Yoshida and Sato, 1989). Analysis of transiently expressed HO-1-GFP fusion gene 
constructs in mouse monocytes by a fluorescence protease protection assay suggested that HO-1 
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anchored in the ER faces the cytosol (Gottlieb et al., 2012). This implied that the breakdown 
products of heme were released into the cytosol. This may not hold true for biliverdin and 
bilirubin as they were amphipathic when conjugated and could insert into lipid membranes 
(Tazuma and Holzbach, 1987). Additionally, palmitoylated HO-1 was targeted to portions of the 
ER membrane proximal to the mitochondria, also known as the mitochondrial-associated 
membrane (Lynes et al, 2012). The proximity of HO-1 to mitochondria could facilitate the 
breakdown of mitochondrial heme proteins. These findings suggest that heme breakdown 
products are proximal to three subcellular locations: the ER membrane, the mitochondrial 
membrane and the cytosol.  
 
1.2 Regulation of ho-1 gene expression 
 Several regulatory cis-acting elements are located upstream of the human and mouse ho-1 
genes, including the musculoaponeurotic fibrosarcoma (MAF; also named the antioxidant 
response element, ARE)) recognition element, the cadmium response element (CdRE) and the 
heat shock element (HSE) as indicated in Figure 1 (Alam et al., 2000; Alam and Cook, 2007; 
Macleod et al., 2009). In terms of trans-acting factors, nuclear factor (erythroid-derived 2)-like 2 
(Nrf2), a basic leucine zipper transcription factor, was determined to be primarily responsible for 
controlling transcription of the ho-1 gene (Alam and Cook, 2007; Ryter et al., 2006). During 
basal conditions, Nrf-2 is situated in the cytosol and bound to Kelch-like enoyl CoA hydratase 
associated protein (Keap1). The Keap1-Nrf2 complex undergoes continuous ubiquitination and 
proteasomal degradation by the Keap1-mediated recruitment of an E3 ubiquitin ligase (Ryter et 
al., 2006). During stress, Keap1-Nrf2 binding is suppressed resulting in the translocation of Nrf2 










Figure 1. Activation of ho-1 gene transcription. Under non-stressed conditions, Nrf2 is associated 
with Keap1, which has been shown to facilitate Nrf2 degradation, while Bach1 blocks Nrf2 
binding at the MARE (inset, lower right). Activation of HO-1 gene transcription is dependent on 
dissociation of Keap1 from Nrf2, which is mediated by stressor modification of Keap1 or the 
action of p38 MAPK. Bach1 dissociation from the MARE is prompted by binding of heme to 
Bach1. Pescadillo has been shown to interact with the CdRE adjacent to the MARE. HSR 










in the ho-1 promoter (Macleod et al., 2009; Stępkowski and Kruszewski 2011). Inhibition of 
Keap1-Nrf2 binding can occur by electrophilic modification of sulfhydryl groups of cysteine 
residues in Keap1 (e.g. sulforaphane) or by MAPK phosphorylation of Nrf2 (Zhang and 
Hannick, 2003; Alam and Cook, 2007; Ryter et al., 2006). Histone deacetylase 6 (HDAC6), a 
component of the heat shock response machinery was reported to deacetylate p38 MAPK, which 
then mediated Nrf2-Keap1 disassociation (Kastle et al., 2012). This process was suggested as 
being the mechanism responsible for HO-1 accumulation in cells treated with proteasomal 
inhibitors (Kastle et al., 2012; Music et al, 2014). Nrf2 activity was also suppressed by Bach1 
(Bric-a-brac and Cap-n-Collar homology), which competed with Nrf2 for binding to the MARE 
and inhibited ho-1 gene expression (MacLeod et al., 2009; Ryter et al., 2006). Hemin/heme-
induced expression of ho-1 genes in mammals and zebrafish involved a Bach1-based mechanism 
(Zenke-Kawasaki et al., 2007; Fuse et al., 2015). Direct binding of heme to Bach1 resulted in the 
recruitment of an ubiquitin ligase to the Bach-1 heme complex (Zenke-Kawasaki et al., 2007). 
This results in the degradation of Bach1 and increased Nrf2 binding (Zenke-Kawasaki et al., 
2007). Bach1 repression was also inhibited in cells treated with cadmium, which promoted 
Bach1’s export to the nucleus (Suzuki et al., 2003).  
 As mentioned previously, heat inducibility of ho-1 genes varied depending on tissue type 
and organism. Analysis of the ho-1 gene in human cells revealed a purine-rich region adjacent to 
the HSE, which is thought to silence the expression of HO-1 in some tissues by an as yet 
undetermined transcription factor(s) and mechanism (Okinaga et al., 1996). However, it was 
suggested that even in tissues where HO-1 did not accumulate in response to elevated 
temperature, heat shock factor 1 (HSF-1) still played a role in ho-1 gene induction since HSF-1 
inhibition reduced ho-1 gene expression (Alam and Cook, 2007). Moreover, HSF-1 bound to the 
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ho-1 gene promoter elements, CdRE and HSE, but was not sufficient for cadmium-induced ho-1 
gene expression (Koizumi et al., 2007). Pescadillo, a transcription factor known to interact with 
the CdRE of the ho-1 gene promoter, may complex with HSF-1 to mediate cadmium-induced ho-
1 gene expression (Sikorski et al., 2006). 
 
 1.3 Mechanisms of HO-1-mediated cytoprotection 
It was mentioned previously that HO-1 increased cell survival by inhibiting oxidative 
damage. HO-1-mediated cytoprotection was suggested to result from the heme breakdown 
products, CO and bilirubin. At low concentrations, CO was shown to have an anti-inflammatory 
effect since it inhibited the expression of pro-inflammatory cytokines, TNF-α and IL-1β genes, 
after exposure to lipopolysaccharide (Otterbein et al., 2000). HO-1-mediated production of CO 
inhibited apoptosis through its interaction with p38 mitogen-activated kinase (MAPK; Brouard et 
al., 2000). Furthermore, bilirubin and biliverdin were reported to be potent antioxidants under 
physiological conditions (Stocker et al., 1987; Morita et al., 1997). For example, bilirubin 
protected against H2O2 -mediated necrotic cell death in HeLa cells and cultured rat neurons 
(Doré et al., 1999; Baranano et al., 2002). Also, bilirubin was shown to decrease lipid 
peroxidation of phosphatidylcholine under physiological conditions (Stocker et al., 1987). As 
biliverdin and bilirubin are amphipathic, they may act as antioxidants in lipid environments.  
 HO-1 may inhibit apoptosis by degrading free heme (Gozzelino et al., 2010). It has been 
suggested that intracellular free heme may promote the production of ROS due to the iron found 
in the heme core, which in turn promoted apoptosis in a TNF-mediated fashion (Gozzelino et al., 
2010). It was postulated that degradation of heme by HO-1 should inhibit this pro-apoptotic 
effect (Gozzelino et al., 2010). This speculative role of HO-1 implies a connection between HO-
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1 and the protein degradation machinery since free heme may accumulate in the cell due to the 
degradation of hemeproteins. This possibility also suggested a role for HO-1 in regulating 
apoptosis in response to the accumulation and degradation of mitochondrial cytochrome C, a 
hemeprotein, which acts as a pro-apoptotic signal molecule in the cytosol (Cai et al., 1998). 
Cytoprotection by HO-1 against a variety of stressors was shown to be suppressed by the 
heme oxygenase activity inhibitors, zinc and tin protoporphyrin (Yang et al., 2003; Srisook et al., 
2005; Varga et al., 2007; Miyake et al., 2010). For example, ZnPP supressed HO-1-mediated 
protection against cadmium stress in rat glial cells while the addition of SnPP abrogated 
protection of mouse T cells from hypoxia by inhibiting HO-1 enzyme activity (Srisook et al., 
2005; Dey et al., 2014). Also, both ZnPP and SnPP inhibited HO-1-mediated cytoprotection of 
rat colons exposed to trinitrobenzene (Varga et al., 2007). ZnPP and SnPP are heme analogs that 
competitively inhibit HO-1 activity (Vreman et al, 1993; Appleton et al, 1999; Wong et al., 2011; 
Rahman et al., 2012). Furthermore, while metalloporphyrins can have effects on other enzymes, 
such as those of the NO synthesis pathway, they are specific for heme oxygenases at 
concentrations described in the present study (Appleton et al., 1999; Wong et al., 2011; Rahman 
et al., 2012).  
 
1.4 Inducers of heme oxygenase accumulation 
 A wide array of stressors was reported to induce HO-1 accumulation in mammalian 
cultured cells (e.g. macrophage, epithelial and fibroblast) including UV radiation, sodium 
arsenite, hydrogen peroxide, cadmium, lipopolysaccharide, and hyperoxia. (Keyse and Tyrell, 
1989; Camhi et al., 1998; Alam et al., 2000; Brouard et al., 2000). Many of the stresses that 
induced HO-1 were found to increase the amount of ROS in the cell (cadmium, hyperoxia) or 
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were themselves ROS, such as hydrogen peroxide (Sarkar et al., 1998; Alam et al., 2000; Hasan 
and Schafer, 2008). Interestingly, stress-induced HO-1 accumulation enhanced cell survival by 
inhibiting apoptosis and reducing oxidative damage (Nath et al., 2000; Nath et al., 2001; Dong et 
al., 2000; Lang et al., 2004). Given the aforementioned findings, HO-1 has been used as a 
biomarker for oxidative stress in the analysis of various disease states such as hypertension, 
hepatic steatosis, silicosis and coronary heart disease (Cheng et al., 2005; Chen et al., 2004; 
Malaguearnera et al., 2005; Sato et al., 2006). Accumulation of HO-1 in response to heat shock 
was shown in human and rat hepatoma cells as well as in rat brain cells but not in human skin 
fibroblasts, human macrophages and rat glioma cells (Taketani et al., 1988; Yoshida et al., 1988; 
Taketani et al., 1989; Keyse and Tyrell, 1989; Mitani et al., 1990; Raju and Maines, 1994). This 
variability in heat-inducible expression has not been fully explained. 
 While a great deal of information regarding mammalian HO-1 accumulation and function 
is available, less is known about HO-1 in poikilothermic vertebrates. However, HO-1 has been 
used as a biomarker for oxidative stress in fish subjected to environmental toxicants. For 
example, increased HO-1 accumulation in response to hypoxia, sodium fluoride, cadmium and 
arsenic was noted in several fish species including zebrafish, goldfish and carp (Lee et al., 1996; 
Motterlini et al., 2000; Wang et al., 2008; Wang and Gallagher, 2013; Jancsó and Hermesz, 2014; 
Mukhopadhyay et al., 2015). Also, exposure of European sea bass to sublethal concentrations of 
a glyphosate-based herbicide resulted in an inhibition of ho-1 mRNA accumulation in the liver 







 Hemin is the chloride salt of heme, an iron-containing metalloporphyrin important to a 
wide array of biological processes across all kingdoms of life. Heme synthesis is a multi-step 
enzyme-catalyzed process that occurs in the cytosol, the intermembrane space and the 
mitochondrial matrix (Heinemann et al., 2008). In animals, the porphyrin ring of heme is 
synthesized from succinyl CoA and glycine prior to the addition of the iron centre (Heinemann et 
al., 2008). Heme is associated with carrier proteins in vivo since free heme is lipophilic (Khan 
and Quigley, 2011). Heme import into the cell appears to involve a dual-functional heme/folate 
import protein (Khan and Quigley, 2011). Several dedicated heme chaperones for intracellular 
trafficking have been identified in bacteria, although corresponding eukaryotic analogs have not 
yet been identified (Severance and Hamza, 2009). Free heme, which circulates in the cytosol, 
was measured to be approximately 20 μM in human erythrocytes (Aich et al., 2016). Increased 
levels of intracellular free heme was reported to elevate ROS levels and cause lipid peroxidation 
and oxidative stress-induced DNA damage (Kumar and Bandyopadhyay, 2005; Khan and 
Quigley, 2011).  
Since heme is the substrate for HO-1 enzyme activity, it is not surprising that hemin 
induces HO-1 accumulation (Alam et al., 1989). In many studies examining the cytoprotective 
nature of HO-1 induction, hemin was often used as an agent to increase the relative levels of HO-
1 prior to a potentially lethal stress (Brouard et al., 2000; Lang et. al., 2004). For example, 
pretreatment with hemin protected rat kidneys against mercury-induced damage by upregulating 
HO-1 levels (Yoneya et al., 2000). Also, hemin-mediated cytoprotection against cadmium-
induced testes damage and cyclophosphamide-induced cystitis in rats was the result of increased 
HO-1 accumulation (Fouad et al., 2009; Matsuoka et al., 2007). Finally, hemin was reported to 
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inhibit protein aggregation in vitro (Liu et al, 2014; Hayden et al., 2015; Sonavane et al., 2017). 
To date this phenomenon has not been demonstrated in vivo. 
 
1.6 Baicalein 
 Baicalein is a flavonoid isolated from Scutellaria baicalensis or Baikal skullcap, an Asian 
plant of the mint family (Li-Weber, 2009). Baicalein was reported to have antioxidant and anti-
inflammatory effects and is currently under investigation as a potential antitumour agent and for 
treatment of cardiac injuries (Li-Weber, 2009, Chen et al., 2006). HO-1 induction by baicalein 
was reported in a number of cell types and may be responsible for the cytoprotective effects of 
the compound. Incubation of rat glioma cells with baicalein was shown to induce the 
accumulation of HO-1, but not HSPs, in a concentration-dependent manner (Chen et al., 2006). 
In this latter study, the cytoprotective effects of baicalein were abolished by treatment with the 
HO-1 activity inhibitor, ZnPP. Another study determined that baicalein enhanced the survival of 
human cardiomyocytes in response to an oxidative stress challenge (Cui et al., 2015). This 
enhancement was suppressed by RNAi-mediated inhibition of the transcription factor Nrf2 (Cui 
et al., 2015). Also, baicalein-induced cytoprotection against palmitate lipotoxicity in rat B cells 
was found to be HO-1 dependent (Kwak et al., 2017). Additionally, a lack of HO-1 involvement 
was reported in baicalein-mediated survival of pig kidney cells treated with peroxynitrite or 
cultured mouse neurons subjected to thapsigargin- or brefeldin A-induced apoptosis (Piao et al., 
2008; Choi et al., 2010). As reported for hemin, baicalein was found to inhibit protein 
aggregation in vitro, which may also contribute to its cytoprotective abilities (Zhu et al., 2004; 
Bomhoff et al., 2006; Kostka et al., 2008). 
Intriguingly, baicalein was also reported to reduce cell survival in certain studies. For 
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instance, baicalein treatment decreased cell survival by preventing cell cycle checkpoint 
progression and inhibiting angiogenesis in xenografted human lung cell tumours (Cathcart et al., 
2017). Baicalein was also shown to reduce proliferation of cultured human endothelial cells (Liu 
et al., 2003). This was believed to occur through a baicalein-vascular endothelial growth factor 
receptor interaction (Ling et al., 2011). It is likely that baicalein has multiple effects on cellular 




 Cadmium is a toxic heavy metal introduced into the environment mainly through fossil 
fuel extraction and mine tailings (Milton et al, 2004; Yusuf, 2007; Boussen et al., 2013; Cullen 
and Maldonado, 2013) Chronic cadmium exposure was reported to primarily affect the kidneys 
where it accumulates and causes a decrease in renal function and tissue necrosis (Armenta and 
Rios, 2007; Nordberg, 2009; Johri et al., 2010; Templeton and Liu, 2010). In kidney, cadmium 
was found to be particularly toxic to renal epithelial tubular cells. Cadmium was also reported to 
induce cancers of the kidney, prostate and lung (Waisberg et al., 2003; Joseph, 2009; Templeton 
and Liu, 2010; Rahimzadeh et al, 2017) Although cadmium is capable of causing DNA damage 
at high concentrations, it was reported that most cadmium-induced carcinogenesis occurs 
through the inhibition of DNA repair or oncogene activation (Waalkes, 2003; Mouchet et al., 
2007; Joseph, 2009) Cadmium import into cells is mediated by the divalent metal transporter 
(DMT1), which is also responsible for rat intestinal absorption of cadmium (Talkvist et al., 2001; 
Park et al., 2002). Zinc transporters, ZIP8 and ZIP14, were also implicated in cadmium uptake in 
an epithelial cell line derived from mouse kidney proximal tubules (Fujishiro et al., 2012). 
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 Cadmium-mediated induction of HO-1 accumulation was reported in a number of 
organisms. For example, in rat testes and mouse mammary cells, HO-1 was shown to accumulate 
in response to cadmium exposure (Alam et al., 1989; Alam et al., 2000). Also, cadmium-induced 
HO-1 accumulation was detected in zebrafish larvae, chicken liver cells, common carp, mung 
bean and cabbage leaves (Sardana et al., 1982; Jin et al., 2012; Wang and Gallagher, 2013; 
Jancsó and Hermesz, 2015; Mahawar et al., 2017). Cadmium is also known to trigger the 
accumulation of heat shock proteins increased in human kidney, rat liver and rat testicles 
(Ovelgonne et al., 1995; Somji et al., 2000; Selim et al., 2012). CdCl2 treatment induced the 
accumulation of HSP24 and HSP70 in chick embryos (Papaconstantinou et al., 2003). Cadmium 
exposure induced HSP70 accumulation in Chinook salmon embryonic and oyster gill cells 
(Heikkila et al., 1982; Ivanina et al., 2008) The endoplasmic reticulum chaperone 
immunoglobulin-binding protein (BiP) accumulated in response to cadmium in chicken 
hepatocytes and pig renal epithelial cells (Liu et al., 2006; Shao et al., 2014). 
 
1.8 Oxidative Stress 
 Organisms are constantly challenged by the presence of oxidative molecules in their 
intracellular environments, which can cause deleterious chemical modifications of DNA, protein 
and/or lipids. Inefficiencies in oxidative phosphorylation result in the production of superoxide 
anions, which can induce the formation of reactive anions that are collectively known as reactive 
oxygen species (ROS; Finkel and Holbrook, 2000; Turrens, 2003; Merksamer et al., 2013). 
These reactive oxygen species include hydrogen peroxide, hydroxyl radicals, peroxynitrite and 
oxidized lipids (Niki et al., 1991; Turrens, 2003). ROS production can occur endogenously or be 
induced or enhanced by the presence of exogenous toxicants including cadmium, sodium 
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arsenite and mercury (Wiggers et al., 2008; Ruiz-Ramos et al., 2009; Cuypers et al., 2010). The 
exact nature of the modifications caused by ROS varies but can include oxidation of cysteine 
thiol groups and/or the peroxidation of lipids (Porter et al., 1995; Tu and Weissman, 2004).  
 A number of defence mechanisms have evolved to counteract the excessive accumulation 
of ROS in the cell. For example, superoxide dismutase (SOD) catalyzes the conversion of 
superoxide to hydrogen peroxide (Turrens, 2003). Hydrogen peroxide is then reduced to water 
and oxygen by catalase. Peroxiredoxins are a family of six (PRDX1-6) enzymes that reduce 
peroxides via a reactive cysteine site on the protein (Yuan et al., 2004). ROS production can also 
be mitigated by the glutathione (GSH) system. Glutathione, also known as (2S)-2-amino-4-
{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid, can reduce 
ROS to non-reactive molecules (Deponte, 2013). After it has reduced a molecule, GSH is 
converted to glutathione disulphide (GSSG; Deponte, 2013). The GSH pool is then regenerated 
from GSSG in an NADPH-requiring process. While these systems are generally sufficient in 
maintaining redox homeostasis, disequilibration can occur. Occasional formation of hydroxy and 
lipid radicals can have a disproportionately large effect on overall ROS levels resulting from a 
self-propogating chain reaction of ROS production (Porter et al., 1995). Since ROS also has a 
role in cell signalling (e.g. hydrogen peroxide activation of cyclic GMP dependent protein kinase 
or platelet derived growth factor-mediated production of hydrogen peroxide), excess ROS 
produced for signalling purposes can remain in the wake of a signalling cascade (Ray et al., 
2012). Futhermore, a wide array of environmental stressors, such as asbestos, radiation and 
heavy metals, can result in ROS generation by overwhelming the redox buffering capacity of the 
cell (Vallyathan and Shi, 1997). When these defence mechanisms are overwhelmed, ROS reacts 
with other cellular components and can modify DNA, lipids and proteins in a way that impedes 
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their proper function. In summary, oxidative stress is the condition that arises when the 
accumulation of ROS begins to have a deleterious effect on the physiology of an organism or 
cell.  
In the process of counteracting oxidative stress, cells may accumulate an excess of 
antioxidant molecules, which theoretically could also cause cellular damage. Studies examining 
this phenomenon, called reductive stress, suggest that reductive agents generally exert their 
effect through dysregulation of antioxidant mechanisms rather than by directly modifying 
proteins, lipids and DNA (Ghyzczy and Boros, 2001). For example in yeast, the presence of the 
small redox proteins known as thioredoxins were required for protection against the reducing 
agent, dithiothreitol (DTT; Trotter and Grant, 2002). In yeast thioredoxin mutants, it was 
reported that the toxic effects of DTT was due to an over-accumulation of the antioxidant, GSH, 
which disrupted endoplasmic reticulum function. Recently, reductive stress was detected in 
animal models of Alzheimer's disease before the onset of cognitive impairment (Lloret et al. 
2016). 
 
1.9 Oxidative stress and unfolded proteins 
 As mentioned above, the deleterious effects of oxidative stress stem, at least in part, from 
their ability to chemically modify proteins. For example, oxidative modifications can alter 
protein secondary structure, which may expose hydrophobic regions making them prone to 
aggregation (Dasuri et al., 2013). This relationship between protein aggregation and oxidative 
stress was reflected in animal research models of Alzheimer's disease, a condition associated 
with the accumulation of misfolded protein. For example, an increase in amyloid plaque 
formation was observed in mice having SOD knockouts as well as in response to an elevation of 
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ROS generation by NADPH oxidase activity (Li et al., 2004; Bruce-Keller et al., 2011). 
Additionally, prolonged oxidative stress can result in proteasomal impairment resulting in an 
inhibition of protein degradation (Aiken et al., 2011). Also, human trabecular meshwork cells 
cultured under hyperoxic conditions showed impairment in their ability to degrade proline-
glutamic acid-serine-threonine (PEST)-enriched green fluorescent protein (GFP) tagged proteins 
(Caballero et al., 2003). Similarly, a loss of proteolytic activity was found in response to ROS 
production by paraquat and iron sulphate in cultured human neuroblastoma cells (SH-SY5Y; 
Ding and Keller, 2001). Thus, oxidative stress may have an impact on misfolded protein 
accumulation by disrupting protein conformation directly and by reducing the rate at which they 
are degraded.  
 Paradoxically, an oxidative environment is also important for proper protein folding. 
Formation of disulphide bonds in proteins in the ER is an oxidative process. Disulphide bridge 
formation is catalyzed by the protein disulphide isomerase (PDI)/Ero1p machinery using 
molecular oxygen as a final electron acceptor, which results in generation of ROS (Tu and 
Weissman, 2004). Consequently, the redox buffering conferred by GSH:GSSH in the ER lumen 
tends to favour more oxidizing conditions than the cytosol (Tu and Weissman, 2004). 
Overexpression of disulphide-rich secretory proteins leads to an increase in the oxidative 
equilibrium in the ER, but also increases the GSH:GSSH ratio in the cytosol (Delic et al., 2012). 
Induction of the unfolded protein response (UPR; induction of ER molecular chaperone gene 
expression in response to an accumulation of unfolded protein) by tunicamycin (N-glycosylation 
inhibitor) decreases the oxidizing condition of the ER (Delic et al., 2012). This was believed to 
reduce the rate of protein folding while misfolded proteins were being degraded (Delic et al., 
2012). The mechanism causing this decrease in oxidizing conditions triggered by the UPR is 
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hypothesized to be the result of a corresponding increase in SOD activity (Tan et al., 2009).  
 The seemingly contradictory roles of oxidizing conditions, being both a cellular stressor 
and a necessary condition for protein folding, can be reconciled by acknowledging the role of 
compartmentalization. A more oxidative environment in the ER allows for protein folding to be 
carried out while preventing the exposure of other cellular compartments to ROS (Go and Jones, 
2008; Jones, 2010). This carries a number of implications for the ER membrane. First, it is 
subjected to higher levels of oxidative stress than the cell in general (Go and Jones, 2008). 
Secondly, as the interface between the ER lumen and the cytosol its redox potential must be 
tightly regulated (Go and Jones, 2008).  
 
1.10 Proteostasis 
 Proteostasis is the maintenance of the synthesis, degradation and conformation of 
proteins within the cell at a non-deleterious level. Of these processes, the maintenance of 
conformation can be directly challenged by non-specific stressors such as heat or oxidative stress 
(Morimoto, 2008). Even in the absence of external stressors, misfolding of proteins can occur 
due to errors in translation or even as a spontaneous phenomenon (Schubert et al., 2000; Kupfer 
et al., 2009). Misfolding of soluble proteins may lead to the exposure of a protein's hydrophobic 
surfaces to the soluble comparments of the cell, which in turn leads to the formation of toxic 
protein aggregates (Morimoto, 2008). Furthermore, some proteins, such as tau and α-synuclein, 
may be more prone to aggregation than others (Bucciantini et al., 2002; Stefani and Dobson, 
2003; Pawar et al., 2006). Protein aggregates were shown to resist degradation by the ubiquitin 
proteasome system (UPS; Salomons et al., 2009). Under most conditions, proteins destined for 
degradation are marked by covalent attachment of multiple ubiquitin molecules through an 
17 
 
enzyme-catalyzed process (Tramutola et al., 2016). These marked proteins are shuttled to the 
proteasome, a multi-megadalton proteolytic complex that deubiquitinates and then degrades 
proteins by an ATP-dependent process (Ross et al., 2015). However, as the proteasome can only 
process linearized polypeptides, protein aggregates are unable to undergo UPS-mediated 
degradation (Salomons et al., 2009). Maintenance of conformation is therefore of critical 
importance to proteostasis in general, as its impairment results in an impairment of protein 
degradation as well.    
 There are several proposed mechanisms by which protein aggregates cause toxicity. It 
was suggested that newly formed protein aggregates sequestered proteins including those 
required for cell survival. This phenomenon was found with aggregates resulting from the 
expression of exogenous genes introduced into cultured human kidney cells (Olzscha et al., 
2011). It has also been hypothesized that as insoluble entities, aggregates interact with cellular 
membranes, altering their permeability and disrupting intracellular cation concentrations (Stefani 
and Dobson, 2003). Alternatively the presence of large macromolecular structures like protein 
aggregates could interfere with molecular trafficking in the crowded cellular environment. 
Nevertheless, these and other studies have shown the inherent toxicity of protein aggregates and 
their possible role in various protein conformation diseases including Huntington's disease, 
Alzheimer's disease and the amyloidoses (Carell and Lomas, 1997; Bayer, 2015). 
 In situations when the amount of aggregated or unfolded protein exceeds the capacity of 
the ubiquitin-proteasome machinery to degrade it, the cell partitions aggregated protein into 
structures called aggresomes, which form proximal to the cell nucleus (Johnson et al, 1998; 
Taylor et al, 2003; An and Statsyuk, 2015). This accumulation of polyubiquinated proteins is 
dependent on histone deacetylase 6 (HDAC6) shuttling polyubiquinated protein along 
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microtubules to the aggresome located at the microtubule organizing complex (MTOC; 
Kawaguchi et al, 2003; Lee et al., 2010). The aggresome is enclosed by a network of vimentin, 
an intermediate filament, which is thought to help stabilize the structure (Johnson et al, 1998; 
Olzmann et al., 2008). Aggresomes are also associated with γ-tubulin, a tubulin isoform found 
primarily at the MTOC (Oakley, 1992; Mi et al., 2009). Aggresomes, which are ultimately 
degraded through autophagy, require the presence of proteasomal complexes in order for this 
mechanism to proceed (Lee et al., 2010; Hao et al., 2013; Nassar et al., 2017). A variety of 
protein chaperones, such as HSP25, HSP27 and HSP30 have been reported to associate with 
aggresomes and aggresome-like structures, suggesting a role for small heat shock proteins 
(sHSPs) in aggresome formation (Ito et al., 2002; Katoh et al., 2004; Goldbaum et al., 2009; 
Bolhuis and Richter-Landsberg, 2010; Khan et al., 2015). 
 
1.11 Heat shock proteins and the heat shock response 
 Heat shock proteins are molecular chaperones that are key components in the 
maintenance of cellular proteostasis. HSPs have been classified into families based on amino 
acid sequence and include sHSPs, HSP40, HSP60, HSP70, and HSP90 (Morimoto, 2008). They 
may be strictly inducible, strictly constitutive or constitutive but responsive to additional 
induction (Morimoto, 1998). HSPs perform a number of roles in maintaining cellular protein 
homeostasis, such as protein folding, preventing aggregation of unfolded proteins and protein 
translocation (Balch et al., 2008). SHSPs, which were found to possess a conserved α-crystallin 
domain, bind unfolded proteins and inhibit the formation of insoluble unfolded protein 
aggregates before transferring them to ATP-dependent chaperones such as HSP70 for refolding 
or degradation (Heikkila, 2004; Morimoto, 2008; Mymrikov et al., 2011; Garrido et al., 2012; 
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Heikkila, 2017).  
 The heat shock response (HSR) is a near-ubiquitous transcriptional response to stresses 
that threaten cellular protein homeostasis such as high temperature, heavy metal toxicants and 
reactive oxygen species (Heikkila, 2004; Voellmy 2004; Morimoto 2008; Heikkila, 2010). More 
specifically, the HSR, which leads to the expression of hsp genes, is activated by the 
accumulation of unfolded proteins, which interferes with proper protein folding or protein 
degradation (Westerheide and Morimoto, 2005; Morimoto 2008). Under non-stress conditions, 
monomeric HSF-1 is normally found in a complex with HSP90 and HDAC6, which renders it 
inactive (Westerheide and Morimoto, 2005; Morimoto 2008). Stress-induced accumulation of 
unfolded or misfolded protein results in HSP90 and HDAC6 dissociating from HSF-1, which 
then, trimerizes, translocates to the nucleus and binds to the HSE (Fig. 2; Voellmy 2004; 
Morimoto 2008; Kastle et al., 2012)  
 
1.12 Xenopus laevis  
 The South African clawed frog, Xenopus laevis, is a well-established model research 
organism. It has been used extensively in developmental studies since its oocytes and embryos 
have properties which make them well suited to research. For example, the large size of Xenopus 
oocytes, including their ability to transcribe injected DNA, makes them amenable for 
microinjection studies (Heikkila et al., 2007). A number of cell lines have been developed, 
including an immortalized A6 kidney epithelial cell line from the proximal renal tubule (Rafferty, 
1969). A6 cells have been used extensively in the study of ion channels by patch clamping for 
over twenty years (Nelson et al., 1984; Nakagawa et al., 1997; Ma, 2011; Thai et al., 2014). They 







Figure 2: Activation of the heat shock response. Various stresses (yellow lightning bolt) lead to 
protein unfolding. Accumulation of unfolded protein results in the disassociation of the HSF-
1/HDAC6/HSP90 complex. HSF-1 trimerizes, translocates to the nucleus and triggers 
transcription of stress induced HSPs by binding to the HSE. HSP90 and the stress-induced HSPs 
then associate with unfolded proteins to inhibit aggregation and promote proper refolding during 














environments (Ikuzawa et al., 2007; Fox et al., 2014; Thit et al., 2015). Finally, as will be 
outlined below, A6 cells have been used to examine various aspects of HSP gene expression and 
function (Heikkila, 2010; 2017). 
 
1.12.1 Stress-induced HSP accumulation in Xenopus cultured cells 
 A number of X. laevis hsp genes have been sequenced, including hsp27, hsp30, hsp47, 
hsp70, hsc70 (heat shock cognate 70 gene), and hsp110 (Heikkila, 2010; 2017). HSP 
accumulation by heat shock, sodium arsenite, CdCl2, herbimycin A and proteasomal inhibitors 
was documented and characterized in A6 cells (Darasch et al., 1988; Briant et al., 1997; 
Woolfson and Heikkila, 2009; Young and Heikkila, 2010; Khamis and Heikkila, 2013). Several 
A6 cell studies also demonstrated a synergistic action of a mild heat shock plus a chemical 
stressor (e.g. sodium arsenite, CdCl2 or proteasomal inhibitors) on HSP accumulation (Heikkila, 
2010; Young and Heikkila, 2010; Khamis and Heikkila, 2013). Furthermore, it was shown that 
A6 cells pretreated with a mild heat shock could survive a lethal thermal challenge (Phang et al., 
1999; Manwell and Heikkila, 2007). Later studies revealed that thermoresistance could also be 
conferred by other stressors including sodium arsenite and the proteasomal inhibitors, cucurmin 
and withaferin A (Young et al., 2009; Khan and Heikkila, 2011; Khan et al., 2012). In A6 cells, 
HSP-mediated aquisition of thermoresistance likely involves the molecular chaperone properties 
of HSPs to inhibit the formation of stress-induced toxic protein aggregates (Heikkila, 2010; 
2017). For example, HSP30 was found to inhibit the heat-induced aggregation of the client 
protein, luciferase, and maintain it in a folding-competent state (Fernando and Heikkila, 2000; 
Abdulle et al., 2002; Fernando et al., 2003). Recently, it was shown that heat shock, CdCl2, 
sodium arsenite and proteasomal inhibitors induced the formation of aggresome-like inclusion 
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bodies that were associated with HSP30 (Khan et al., 2015). 
 
1.12.2 Stress-induced HO-1 accumulation in X. laevis 
 In contrast to HSPs, little information is available regarding X. laevis HO-1. In 2008, Shi 
et al. (2008) sequenced X. laevis HO-1 and detected the presence of ho-1 mRNA during early 
embryogenesis. Also, treatment of adult male X. laevis with the endocrine disruptor, 17-
ethinylestradiol, caused decreased levels of ho-1 and ho-2 mRNA (Gamshausen et al., 2015). 
Recently, HO-1 was reported to accumulate in A6 cells subjected to sodium arsenite or CdCl2 
treatment in a concentration- and time-dependent manner (Music et al., 2014). In this latter study, 
HO-1 accumulation was inhibited by addition of actinomycin D or cycloheximide, suggesting de 
novo transcription. While heat shock did not induce HO-1, mild heat shock was reported to 
enhance HO-1 accumulation in response to exposure to low concentrations of CdCl2 or sodium 
arsenite (Music et al., 2014; Shirriff and Heikkila, 2017). Recently, HO-1 accumulation was 
shown to be upregulated by two sulphur containing plant secondary metabolites namely, benzyl 
isothiocyanate and phenethyl isothiocyante in X. laevis cells (Khamis and Heikkila, 2018). Also, 
proteasomal inhibitors induced HO-1 accumulation in A6 cells at lower concentrations than 
reported in mammalian systems (Music et al., 2014). In the aforementioned studies, HO-1 was 
found to accumulate in the perinuclear region of the cytoplasm, which was consistent with 
observations of HO-1 being an ER protein (Ryter et al., 2006). In summary, these studies suggest 
that HO-1 accumulation may be a useful biomarker for toxicants for aquatic poikilothermic 





1.13 Hypothesis and Objectives 
 Stress-induced HO-1 accumulation remains largely uncharacterized in X. laevis and other 
amphibians. Previously, as mentioned in Section 1.12.3, HO-1 accumulation in A6 cells after 
treatment with selected stressors was demonstrated, but its ability to confer cytoprotection has 
not. Furthermore, to the best of my knowledge, there have not been any studies examining the 
effect of hemin or baicalein on HO-1 accumulation in Xenopus. Additional information on HO-1 
gene expression and function in amphibians and other aquatic poikilotherms is of importance 
given the presence of toxic heavy metals, metalloids and other contaminants in their habitats. It 
is possible that HO-1 accumulation could act as a molecular biomarker of oxidative stress (Music 
et al., 2014; Shirriff and Heikkila, 2017). 
In a broader context, manipulating the accumulation of HO-1 in different human tissues 
may be of therapeutic value in certain disease states. For example, it was reported that the 
catalytic by-products of heme have anti-apoptotic and angiogenic effects in tumour cells, which 
can be diminished by administration of ZnPP, an inhibitor of HO-1 activity. HO-1-mediated 
cytoprotection assessed by the maintenance of control-like levels of aggregated protein or 
control-like actin cytoskeletal structure, was found to be of particular importance during acute 
kidney injury resulting from ischemia, infection or transplant rejection (Shimizu et al., 2000; 
Blydt-Hansen et al., 2003; Tracz et al., 2007; Nath, 2014). Given that cellular processes are 
generally conserved through vertebrate evolution, research with Xenopus A6 kidney epithelial 
cells provides a model tissue culture system for understanding the mechanism(s) associated with 





Hypothesis: I hypothesize that hemin and baicalein will induce HO-1 accumulation in X. laevis 
A6 cells and that they will also confer cytoprotection against a near-lethal CdCl2 stress challenge. 
Furthermore, this cytoprotection will be suppressed by HO-1 activity inhibitors.  
 
The main objectives for this doctoral research are as follows: 
1. Examine the effect of hemin and baicalein on HO-1 accumulation in Xenopus.  
In mammalian systems, HO-1 was demonstrated to accumulate in response to hemin by a Bach-
1-based mechanism. Investigating whether hemin elicits a similar accumulation in Xenopus cells 
will determine if the cellular response to hemin is conserved in non-mammalian vertebrates and 
serves as a foundation for future comparative studies of HO-1 using amphibians and other 
poikilotherms.  
 
2. Determine if HO-1 confers cytoprotection in cultured Xenopus cells exposed to near lethal 
concentrations of CdCl2. HO-1 was found to confer cytoprotection in mammals, but this 
phenomenon has not been examined in amphibians or other vertebrate poikilotherms. 
Determination of whether HO-1 has the ability to confer cytoprotection against cadmium in 
Xenopus helps to characterize its physiological role and to emphasize its potential value as a 
biomarker of oxidative stress in amphibians and other aquatic vertebrates. 
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2.0 Materials and methods 
2.1 Chemicals 
Hemin (Sigma-Aldrich, Oakville, ON) was prepared by dissolving it in dimethyl 
sulfoxide (DMSO; Sigma-Aldrich) to yield a 1.5 mM stock solution. HO-1 enzyme activity 
inhibitors, tin protoporphyrin (SnPP; Enzo Life Sciences, Farmingdale, NY) and zinc 
protoporphyrin (ZnPP; Enzo Life Sciences) were dissolved in DMSO to produce 1.5 mM stock 
solutions. Baicalein (Sigma-Aldrich) was also dissolved in DMSO to produce a 10 mM stock 
solution. After stocks were made, hemin, ZnPP, SnPP and baicalein were kept wrapped in tin foil 
to protect from light and stored at -20 °C. CdCl2 (Bioshop, Burlington, ON) was prepared as a 
100 mM stock solution in sterile water (Sigma-Aldrich). In experiments with DL-buthionine 
sulfoximine (BSO; Sigma-Aldrich), a 200 mM stock solution of was freshly prepared before 
each treatment by dissolving it in sterile water (Sigma-Aldrich). Stocks of actinomycin D 
(Sigma-Aldrich) were prepared by mixing with DMSO to a final concentration of 2 mg/ml. 
Cycloheximide (Sigma-Aldrich) stock was prepared in sterile water (Sigma-Aldrich) at a 
concentration of 10 mM. KNK437 (Sigma-Aldrich) stock was prepared with DMSO at a 
concentration of 5 mg/ml. 
 
2.2 Culture of Xenopus laevis A6 kidney epithelial cells 
 Xenopus laevis A6 kidney epithelial cells were obtained from the American Type Culture 
Collection (CCL-102; Rockville, MD). Cells were cultured in T75 cm2 flasks (VWR, 
Mississauga, ON) at 22 ºC using 70% L15 (Leibowitz) cell culture media with 10% fetal bovine 
serum and 1% penicillin/streptomycin (Sigma-Aldrich). Once the cells were confluent, they were 
rinsed once with 1 ml versene [0.02% (w/v) KCl, (0.8% (w/v) NaCl, 0.02% (w/v) KH2PO4, 
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0.115% (w/v) NaHPO4, 0.02% (w/v) Na2EDTA] and then again with 2 ml versene followed by 
treatment with 1 ml of 1X trypsin (Sigma-Aldrich) in Hank's balanced salt solution (HBSS, 
Sigma-Aldrich) to facilitate cell detachment. Fresh media was then added to resuspend cells and 
inactivate trypsin followed by transfer of cells to new flasks.  
 
2.3 Cell treatments 
Treatments were administered to cells at 90% confluency. In experiments using 10 to 30 
µM hemin, 50 to 400 µM baicalein or 25 to 275 µM CdCl2 alone, they were mixed with L-15 
media and administered to the cells at the final concentration described. The effect of 
transcriptional inhibition on HO-1 accumulation involved pretreatment of cells for 30 min with 2 
µg/mL actinomycin D (Sigma-Aldrich) at 22 °C before the addition of hemin or baicalein to the 
cell media. Investigation of the effect of the translational inhibitor, cycloheximide, involved 
pretreatment of cells with 100 µM cycloheximide (Sigma-Aldrich) for 6 h at 22 °C prior to the 
addition of hemin or baicalein. In studies determining the effect of HSF1 inhibition on HO-1 
accumulation, cells were pretreated for 6 h with 100 µM of the HSF1 inhibitor KNK437 (Sigma-
Aldrich; dissolved in DMSO) prior to the addition of hemin or baicalein. Additionally, some 
flasks of cells were incubated for 4 h with 10 mM BSO at 22 °C followed by supplementation 
with hemin, baicalein or CdCl2 for 16 h. In experiments examining HO-1 enzyme activity 
inhibitor effects on cadmium-treated cells, cells were treated with ZnPP or SnPP for 4 h prior to 
supplementation with 50 µM CdCl2 for 16 h at 22 °C. Finally, cytoprotection studies required the 
incubation of cells with baicalein or hemin and/or 15 μM SnPP for 4 h prior to supplementation 




2.4 Protein isolation and quantification  
 Prior to collection, cells were rinsed once with 2 ml of 65% HBSS and then resuspended 
in 1 ml 100% HBSS. Cells were transferred to a 1.5 ml microcentrifuge tube (Eppendorf 
centrifuge; Model No. 5810R; Mississauga, ON) and collected by centrifugation at 14,000 rpm 
for 1 min and then stored in 1.5 ml microcentrifuge tubes at -80 °C. For protein isolation, cells 
were lysed using 300 µL of 1% SDS lysis buffer (200 mM sucrose, 2 mM EGTA, 1 mM EDTA, 
40 mM NaCl, 30 mM HEPES, pH 7.4, 1% protease inhibitor and 1% SDS) and then pulse 
sonicated at 10 watts for 30 s on ice (Model 100, Fisher Scientific; Waltham, MA, USA). Cell 
debris and unlysed cells were separated from the protein isolate by centrifugation at 14,000 rpm 
for 60 min at 4 °C. Protein content of the supernatant was quantified by the bicinchoninic acid 
protein quantification assay kit (Pierce, Rockford, IL, USA). Protein standards were made by 
diluting a bovine serum albumin (BSA; Bioshop) solution with MilliQ water to final 
concentrations ranging from 0 to 2 mg/mL. Standards and samples were transferred in triplicate 
to a polystyrene 96-well plate followed by the addition of the assay reagents. The plate was then 
incubated at 37 °C for 30 min and monitored at 562 nm using a Versamax Tunable microplate 
reader (Molecular Devices, Sunnyvale, CA, USA) and Softmax Pro software.  
 
2.5 SDS-PAGE and immunoblot analysis 
 Protein samples were separated by sodium dodecyl-sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) using 12% acrylamide gels. Gels were electrophoresed for 10 min 
at 90 V followed by an increase in voltage to 160 V for the remainder of the procedure. Protein 
was transferred from acrylamide gels to nitrocellulose membranes using a Trans-Blot Semi-dry 
transfer system (Bio-Rad, Mississauga, ON) for 25 min at 20 V. Transfer efficiency was assessed 
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by protein staining with Ponceau S (Sigma-Aldrich). Blots were incubated for 1 h in 5% skim 
milk (Carnation, Markham ON) in Tris buffered saline (20 mM Tris pH 7.5, 300 mM NaCl) with 
0.1% Tween-20 (TBS-T; Sigma-Aldrich) to inhibit non-specific protein binding. The membranes 
were incubated with rabbit anti-HO-1 antibody (1:500; Enzo Life Sciences; Catalog no. BML-
HC3001-100), rabbit anti-Xenopus HSP70 (1:350; commercially made against a 16 amino acid 
C-terminal peptide fragment of X. laevis HSP70B; Abgent, San Diego, CA, USA; Gauley et al., 
2008), rabbit anti-Xenopus HSP30 (1:500; Fernando and Heikkila, 2003), rabbit anti-SOD1, 
(1:150 ; Genetex, Irvine CA; Catalog no. GTX13498), rabbit anti-Nrf2 (1:200 Abcam, 
Cambridge MA; Catalog no. 92946), rabbit anti-PRDX5 (1:500; Abcam; Catalog no. 86086) or 
rabbit anti-actin (1:200; Sigma; Catalog no. A2066) polyclonal antibodies and a mouse anti-α-
tubulin monoclonal antibody (1:500; Sigma; Catalog no. T9026) diluted in 5% skim milk 
solution and left overnight. Membranes were then washed with TBS-T for 15 min and then twice 
for 10 min each followed by incubation with alkaline phosphatase-conjugated goat-anti-rabbit 
antibodies (BioRad) in TBS-T with 5% blocking for 1 h at 22 °C. Membranes were rinsed with 
TBS-T for 15 min followed by two 5 min rinses. Bands were then visualized by incubating blots 
in alkaline phosphatase detection buffer (100 mM Tris pH 9.5, 100 mM NaCl, 50 mM MgCl2) 
with 0.3% nitro blue tetrazolium (Roche) and 0.17% 5-bromo-4-chloro-3-idolyl phosphate 
toluidine salt (Roche).  
 
2.6 Densitometry 
 Densitometric analysis of immunoblots was performed using Image J software (Version 
1.49; National Institute of Health; http://rsb.info.nih.gov/ij/) to quantify band intensity. The band 
intensity of each sample was expressed as a percentage of the maximum value for HO-1, HSP70, 
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HSP30 or SOD1 in a particular trial. The band intensities of Nrf2 and PRDX5 were expressed as 
a n–fold increase of the control band intensity. The percentages for a given treatment were 
averaged across three replicates and graphed. In studies where a consistent Standard error of the 
mean was indicated as vertical error bars. Significance (p < 0.05% or p < 0.1%) between control 
and treatment intensity was determined using one-way ANOVA with Tukey's post hoc test.  
 
2.7 Immunocytochemistry and laser scanning confocal microscopy (LSCM) 
 Cells for LSCM imaging were grown on flame sterilized base-washed coverslips in Petri 
dishes (VWR, Catalog no. 351029). Specifically, 22 x 22 mm glass coverslips (VWR; Catalog 
no. 48366-067) were washed with a base solution [49.5% (v/v) ethanol, 0.22 M NaOH] in small 
staining jars (Thomas Scientific Apparatus, Philadelphia, PA, USA) for 30 min and then rinsed 
with distilled water for 3 h. Cells were grown to 50% confluency prior to the addition of 
treatments to minimize the risk of over-confluency in LSCM images. Treatments were added to 
media then applied to Petri plates containing coverslips. Supplementation with additional agents 
was performed by adding the substance to already treated cells in Petri dishes followed by 
mixing by gentle agitation. Timing and concentration of treatments was as described in section 
2.3. Following treatment, coverslips were rinsed with phosphate-buffered saline with magnesium 
and calcium (PBS; 1.37 M NaCl, 67 mM Na2HPO4, 26 mM KCl, 14.7 mM H2PO4, 1 mM CaCl2, 
0.5 mM MgCl2 pH 7.4). Coverslips were then transferred to small Petri dishes and fixed with 
3.7% paraformaldehyde (BDH Inc., Toronto, ON) in PBS for 15 min. Coverslips were washed 
three times for 5 min each and then permeabilized with 0.3% Triton X-100 (TX-100; Sigma-
Aldrich) in PBS for 10 min. Coverslips were washed 3 times with PBS for 2 min each and then 
incubated in 3.7% BSA in PBS overnight at 4 °C. They were then incubated with a 1:250 
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dilution of rabbit anti-HO-1 primary antibody (or 1:500 anti-HSP30 or 1:250 anti--tubulin) in 
PBS w/ 3.7% BSA solution for 1 h at 22 °C. After incubation, the coverslips were washed 3 
times with PBS and then incubated with a 1:2,000 dilution of fluorescent-conjugated goat anti-
rabbit Alexa Fluor 488 secondary antibody (Invitrogen Molecular Probes, Carlsburg, CA) in PBS 
with 3.7% BSA for 30 min followed by 3 washes with PBS. For actin visualization, coverslips 
were incubated in PBS with 3.7% BSA containing a 1:60 dilution of rhodamine-
tetramethylrhodamine-5-isothiocyanate phalloidin (TRITC; Invitrogen Molecular Probes) for 15 
min. After washing, coverslips were allowed to dry and then mounted on glass slides using 
Vectashield mounting medium (Vector Laboratories, Burlingame CA) with 4, 6-diamidino-2-
phenylindole (DAPI). Slides were sealed using clear nail polish and stored at 4 °C until viewed 
using a Zeiss Axiovert 200 confocal microscope with LSM 510 META software (Carl Zeiss 
Canada Ltd., Mississauga, ON). 
 
2.8 CellRox Green oxidative stress detection assay 
 In experiments using CellRox Green, cells were grown on flame sterilized base-washed 
coverslips in Petri dishes (VWR, Catalog no. 351029). Cells were cultured on glass coverslips 
for 4 h with either media or media containing 25 µM hemin, 100 µM baicalein, 200 μM CdCl2 or 
10 mM BSO at 22 °C. One hour prior to fixation, CellRox Green dye was added to the cell 
media at a final concentration of 5 µM and kept in the dark. Coverslips were then transferred to 
small Petri dishes and fixed with 3.7% paraformaldehyde (BDH Inc. Toronto, ON). Coverslips 





2.9 Proteostat aggregation assay 
In experiments using the Proteostat aggresome detection kit (Enzo Life Sciences), cells 
were grown on flame sterilized base-washed coverslips in Petri dishes. Hemin, baicalein, CdCl2 
and the HO-1 enzyme activity inhibitors ZnPP and SnPP were applied as described in the cell 
treatment section 2.3. In experiments examining HO-1 enzyme activity inhibitor effects on 
cadmium-treated cells, cells were treated with ZnPP or SnPP for 4 h at 22 °C prior to 
supplementation with 50 µM CdCl2 for 16 h at 22 °C. For cytoprotection studies, cells were 
cultured with baicalein or hemin and/or 15 μM SnPP for 4 h at 22 °C prior to supplementation 
with 275 µM CdCl2 for 16 h, followed by a 4 h recovery in fresh media. Following treatment, 
coverslips were fixed, permeabilized and incubated in 3.7% BSA in PBS overnight at 4 °C as 
described above. They were then incubated with a 1:1000 dilution of Proteostat detection reagent 
in PBS containing 3.7% BSA solution for 1 h at 22 °C. They were then incubated with a 1:250 
dilution rabbit anti-HO-1 primary antibody in PBS w/ 3.7% BSA solution for 1 h at 22 °C. 
Coverslips were washed 3 times with PBS and then incubated with a 1:2,000 dilution of 
fluorescent-conjugated goat anti-rabbit Alexa Fluor 488 secondary antibody (Invitrogen 
Molecular Probes) in PBS with 3.7% BSA for 30 min followed by 3 washes with PBS. 
Coverslips were allowed to dry and then mounted on glass slides as previously described. 
 
2.10 Bioinformatic analysis 
 A multiple amino acid sequence alignment was performed with X. laevis (Genbank 
accession no NP_001089909.1), X. tropicalis (Genbank accession no XP_002934766.1) and H. 
sapiens HO-1 sequences using Clustal Omega (Version O.2.1; 
https://www.ebi.ac.uk/Tools/msa/clustalo/; Sievers et al., 2011). A multiple amino acid sequence 
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alignment using Clustal Omega was also carried out using representative sequences from 
mammals, fish, reptiles and birds. Three dimensional ribbon modelling of X. laevis (Genbank 
accession no NP_001089909.1) and H. sapiens HO-1 (Genbank accession no. NP_002124.1) 
was performed using the RaptorX prediction server. (http://raptorx.uchicago.edu; Källberg et al., 
2012). Models were then converted into two-dimensional images using UCSF Chimera v.1.10.2 
(https://www.cgl.ucsf.edu/chimera/; Pettersen et al., 2004). Analysis of the Xenopus laevis ho-1 
promoter region was performed using sequence data obtained from Xenbase (J-strain v 9.1; 
http://www.xenbase.org/, chr4L:107491000..107495999). This region was compared to the 
upstream region of the H. sapiens ho-1 gene (NCBI; NC_000022.11). Putative cis-acting 
elements were identified based on corresponding elements found in the human ho-1 promoter 





3.1 Characterization of the heme oxygenase-1 (HO-1) amino acid sequence in X. laevis. 
Stress-inducible HO-1 protein accumulation and function has been examined primarily in 
mammalian model systems including human, mouse, and rat (Alam et al., 2000; Balogun et al, 
2003; Chen et al., 2011; Gonzales-Reyes et al., 2013; Detsika et al., 2015). In order to compare 
the properties of HO-1 in X. laevis cells to mammalian HO-1, a series of in silico analyses were 
carried out. Initially, a comparison of the percent identity of X. laevis HO-1 amino acid sequence 
(Genbank accession no. NP_001089909) with HO-1 sequences from an amphibian, X. tropicalis, 
and selected birds, mammals, reptiles, and fish was performed (Table I). While X. laevis HO-1 
shared 91% identity with X. tropicalis HO-1, the percent identity with HO-1 from other animals 
ranged from 50 to 64%. Also the percent identity of X. laevis HO-1 with H. sapiens and X. laevis 
HO-2 were 62 and 53%, respectively. This initial analysis was followed by a more detailed 
comparison of Xenopus and H. sapiens HO-1 (Fig. 3). Using the well-studied human HO-1 
amino acid sequence as a reference, X. laevis and X. tropicalis HO-1 were determined to have 8 
heme-binding pocket residues (K21, T24, H28, Y137, G146, L150, K182, F210; indicated in 
red), which included an iron-binding histidine (H28; indicated with an arrow). A highly 
conserved HO-1 signature sequence described in other animal HO-1 proteins was also found in 
X. laevis (Maines and Gibbs, 2005). Fig. 3 also depicts a 14 amino acid sequence in human HO-1 
(underlined) that is identical to X. laevis HO-1 that was used to generate an anti-HO-1 antibody 
(Enzo Life Sciences). This antibody was employed in this study to detect Xenopus HO-1 
accumulation in immunoblot and immunocytochemical analyses.  
In a further comparison of H. sapiens and X. laevis HO-1, three-dimensional ribbon 







A comparison of Xenopus laevis HO-1 with selected HO-1 and HO-2 from  
other organisms.  
_____________________________________________________________________________________ 
Percent identity with Xenopus laevis HO-1 (NP_001089909.1)            (%) 
_____________________________________________________________________________________ 
 
X. tropicalis HO-1 (XP_002934766.1)     91 
 
C. striatus HO-1 (XP_010195140.1)      64 
G. gallus HO-1 (NP_990675.1)      63 
A. cygnoides domesticus HO-1 (XP_013036532.1)    63 
 
M. brandtii HO-1 (EPQ19396.1)      62 
H. sapiens HO-1 (NP_002124.1)      61   
M. musculus HO-1 (NP_037215.1)      59 
 
A. carolensis HO-1 (XP_003220978.2)     61 
G. japonicus HO-1 (XP_015265521.1)     60 
P. mucrosquamatus HO-1 (XP_015687234.1)    56 
 
D. rerio HO-1 (NP_001120988.1)      54 
F. heteroclitus HO-1(XP_012723342.1)     54 
C. carpio HO-1(AGI05156.1)      50 
 
H. sapiens HO-2 (BAA04789.1)      62 
X. laevis HO-2 (NP_001085675.1)      53 
_____________________________________________________________________________ 
 
An amino acid sequence comparison of Xenopus laevis HO-1 with HO-1 sequences from the 
amphibian, Xenopus tropicalis, and selected birds, mammals, reptiles, and fish as well as 








Figure 3. Alignment of Xenopus laevis, Xenopus tropicalis and Homo sapiens HO-1 amino acid 
sequences. Alignment of X. laevis (Genbank accession no NP_001089909.1), X. tropicalis 
(Genbank accession no XP_002934766.1) and H. sapiens HO-1 (Genbank accession no. 
NP_002124.1) was performed using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/; 
Sievers et al., 2011). Identical amino acids are denoted by asterisks. Conservative amino acid 
substitutions are represented by colons and semi-conservative by periods. Deletions are indicated 
by dashes in the amino acid sequence. Residues associated with the heme-binding pocket are 
coloured red while the iron-binding histidine is indicated with an arrow. The highly conserved 
HO-1 signature region is highlighted in grey. Amino acids forming the peptide used to generate 







                                                 
X. laevis            MDPSASQQYKSTHEDLSEALKEATKEVHVQAENTEFMRNFQKGQVSLEEFKLVMSSLYFI 60 
X. tropicalis        MDPSASQQLKSSLKDLSEALKEATKEVHVQAENTEFMRNFQKGQVSLEEFKLVMSSLYFI 60 
H. sapiens           ---MERPQPDSMPQDLSEALKEATKEVHTQAENAEFMRNFQKGQVTRDGFKLVMASLYHI 57 
                            * .*  :**************.****:***********: : *****:***.* 
 
X. laevis            YEALEEEINRNKDNPVFSPVYFPLELHRKNALEVDLEYFYGPQWRKKIICPHSTKNYVDR 120 
X. tropicalis        YEALEEEINRNKDNPVFSPVYFPMELHRKNALEEDLEYFYGPQWRKKIICPRSTKNYVDR 120 
H. sapiens           YVALEEEIERNKESPVFAPVYFPEELHRKAALEQDLAFWYGPRWQEVIPYTPAMQRYVKR 117 
                     * ******:***:.***:***** ***** *** ** ::***:*:: *    : :.**.* 
 
X. laevis            LHHVGQKEPELLVSHAYTRYLGDLSGGQVLKKIAQKALQLPASGEGLAFFTFDNVTNATK 180 
X. tropicalis        LHQVGQNEPELLVSHAYTRYLGDLSGGQVLKKIAQKALQLPASGEGLAFFTFDNVTNATK 180 
H. sapiens           LHEVGRTEPELLVAHAYTRYLGDLSGGQVLKKIAQKALDLPSSGEGLAFFTFPNIASATK 177 
                     **.**:.******:************************:**:********** *::.*** 
 
X. laevis            FKQLYRSRMNSIETDAYAKKRILEEAKTAFLLNIKLFEELQTLSLATSQNGNTRTEATEL 240 
X. tropicalis        FKQLYRSRMNSIEMNTHNMNRILEEAKTAFLLNIKVFEELQTLSLAASQN---RTEATEL 237 
H. sapiens           FKQLYRSRMNSLEMTPAVRQRVIEEAKTAFLLNIQLFEELQELLTHDTKDQSP-SRAPGL 236 
                     ***********:*      :*::***********::***** *    :::    :.*  * 
 
X. laevis            RSRGPKT-ENGRPTKTDNRENNSSSEEQPTTFLRWFLIAGCALIT-LMGLYIF  291 
X. tropicalis        RSRGHKT-ENGSPAKTENRENNGSSEEQPTTFLRWLLIAGCALIT-LMGLYIF  288 
H. sapiens           RQRASNKVQDSAPVET-PRGKPPLNTRSQAPLLRWVLTLSFLVATVAVGLYAM  288 















determine if there were any obvious structural differences between the two proteins (Fig. 4). 
While the interpretations that can be drawn from 3D structure predictions are limited, the two 
proteins appear to have similar structural features. Based on earlier structural analysis of HO-1  
by Schuller et al. (1999), both human and X. laevis HO-1 have a hemin-binding pocket that was 
formed mainly by an alpha-helix containing the iron-binding histidine (red) and a second kinked 
alpha-helix present on the other side of the pocket. Both human and Xenopus models of HO-1 
also show the presence of a membrane anchoring C-terminal helix along with a flexible linker 
region attached to the globular portion of the HO-1 enzyme.  
 
3.2 Pattern of HO-1 accumulation in cells treated with hemin, baicalein or CdCl2 exposure 
The present study examined the effect of different concentrations of hemin, baicalein and CdCl2 
on HO-1 accumulation in X. laevis A6 cells by immunoblot and subsequent densitometric 
analysis. As shown in Fig. 5A, maximal levels of HO-1 occurred in cells incubated for 16 h with 
25 μM hemin. Densitometric analysis revealed that while control cells had very low levels of 
HO-1, cells treated with 10, 15, 20 and 30 μM hemin displayed HO-1 levels that were 65%, 
83%, 90%, and 94%, respectively, of peak values (Fig. 5B). HSP70 and HSP30 were not 
detectable at any of the hemin concentrations employed (data not shown). In cells treated with 
baicalein for 16 h, elevated levels of HO-1 were observed at 50 μM and 100 μM with peak levels 
at 200 μM while treatment at 400 μM resulted in a reduction to 60% of its peak value (Fig. 6). 
HSP70 and HSP30 accumulation was not detected in response to baicalein treatment (data not 
shown). Finally, treatment of cells with 200 μM CdCl2 showed the highest levels of HO-1 







Figure 4. Comparison of X. laevis and H. sapiens HO-1 structure. The amino acid sequences of 
X. laevis (Genbank accession no NP_001089909.1) and H. sapiens HO-1 (Genbank accession 
no. NP_002124.1) were used to generate three-dimensional ribbon models of the Xenopus and 
human HO-1 protein (http://raptorx.uchicago.edu/StructurePrediction/predict/; Källberg et al., 
2012). UCSF Chimera was used to visualize the models. Indicated on the models are residues 
associated with the heme-binding pocket (orange), the putative iron-binding histidine (red; also 
part of the heme-binding pocket), residues associated with the C-terminal transmembrane region 
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Figure 5. Effect of different concentrations of hemin on HO-1 accumulation. A) Cells were 
maintained, untreated at 22 °C (C) or treated with either 10, 15, 20, 25 or 30 μM of hemin or 50 
μM of CdCl2 for 16 h at 22 °C. Proteins were isolated and used to generate an immunoblot using 
anti-HO-1 and anti-actin antibodies as described in Materials and methods (a representative 
immunoblot is shown). Bands for HO-1 and actin were detected at 32 kDa and 42 kDa 
respectively. CdCl2 was used as a positive control since it was previously shown to induce 
accumulation of HO-1 in A6 cells (Music et al., 2014). B) Densitometric analysis of HO-1 
accumulation. The results were expressed as % mean relative density in comparison to the 
maximum band density obtained for HO-1 (25 μM hemin). Standard error was indicated by the 
vertical bars. A one-way ANOVA and a Tukey’s post-hoc test was used to determine 
significance (p < 0.05), as represented by an asterisk, between control cells and treated cells. 
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Figure 6. Concentration-dependent accumulation of HO-1 in response to baicalein treatment. A) 
Cells were maintained, untreated at 22 °C (C) or treated with 50, 100, 200 or 400 μM of 
baicalein for 16 h at 22 °C. Immunoblot analysis of isolated proteins employed anti-HO-1 and 
anti-actin antibodies. B) Densitometric analysis of HO-1 accumulation was performed as 
described in Materials and methods. The results were expressed as % mean relative density 
compared to the maximum density (200 μM baicalein) as indicated in the legend of Figure 3. 
The error bars indicate standard error of the mean while the significance (p < 0.05) compared to 
control was determined by the one-way ANOVA test and Tukey’s post-hoc test and represented 
by an asterisk. These data are representative of 3 separate experiments.
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Figure 7. Effect of different concentrations of CdCl2 on HO-1, HSP70 and HSP30 accumulation. 
A) Cells were maintained, untreated at 22 °C (C) or treated with 25, 50, 100 or 200 μM of CdCl2 
(Cd) for 16 h at 22 °C. A. Immunoblot analysis was performed as stated in the Materials and 
methods employing anti-HO-1, anti-HSP70 (detected at 70 kDa), anti-HSP30 (detected at ~24 
kDa) and anti-actin antibodies as described in Materials and methods. B) Densitometric analysis 
of HO-1 (black), HSP70 (grey) and HSP30 (white) accumulation. The results were expressed as 
% mean relative density of each protein in comparison to the maximum density (HO-1, HSP70 
and HSP30 at 200 μM CdCl2). The error bars indicate standard error of the mean while the 
significance (p < 0.05) compared to control was determined by the one-way ANOVA test and 
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Cells treated with 25, 50 or 100 μM CdCl2 resulted in HO-1 levels that were 18%, 48% 
and 88%, respectively, of peak levels at 200 M. In contrast to hemin and baicalein, CdCl2 
treatment also induced the accumulation of HSP70 and HSP30. Inducible levels of HSP30 and 
HSP70 were observed with 25 μM and 100 μM CdCl2, respectively, with the highest levels at 
200 μM. These findings were consistent with previous studies in our laboratory examining the 
effect of CdCl2 on HO-1, HSP70 and HSP30 levels in our laboratory (Woolfson and Heikkila, 
2009; Khamis and Heikkila, 2013; Music et al., 2014). Finally, the relative levels of actin 
remained constant in A6 cells treated with different concentrations of hemin, baicalein or CdCl2. 
Time course experiments revealed temporal-dependent increases in hemin-, baicalein- 
and CdCl2 -induced HO-1 accumulation. For example, in cells treated with 25 μM hemin, 
significant accumulation of HO-1 was detected at 8 h followed by an increase to its peak amount 
at 12 h (Fig. 8A). Decreased levels of CdCl2 -induced HO-1 accumulation were observed at 16, 
24 and 48 h, which had levels of 73%, 40% and 22%, respectively, compared to the peak value at 
12 h (Fig. 8B). In cells incubated with 100 μM baicalein, maximum levels of HO-1 were 
detected at 16 h (Fig. 9A). Relative to peak values of baicalein-induced HO-1, lower amounts 
were observed at 12 h (48%) and 24 h (51%) time points (Fig. 9B). In 200 μM CdCl2 -treated 
cells, the highest levels of HO-1, HSP70 and HSP30 were observed at 24 h, the final time point 
(Fig. 10A). HO-1 and HSP70 were first detected at 8 h having 14% and 42% of peak values, 
respectively, followed by a further enhancement to 70% and 89%, respectively, at 16 h (Fig. 
10B). A statistically significant accumulation of HSP30 (62%) compared to 24 h levels was first 
detected at 16 h. The levels of actin remained constant in all of the time course experiments with 
hemin, baicalein and CdCl2.  








Figure 8. Time course of HO-1 accumulation in response to hemin. A) Cells were maintained at 
22 °C for 16 h (C) or were incubated with 25 μM hemin and harvested after 4, 8, 12, 16, 24 or 48 
h at 22 °C. Isolated proteins were examined by immunoblot analysis using anti-HO-1 and anti-
actin antibodies. B) Densitometric analysis of HO-1 accumulation. The results were expressed as 
% mean relative density compared to maximum density (12 h time point) as indicated in the 
legend of Figure 3. The error bars indicate standard error of the mean while the significance (p < 
0.05) compared to control was determined by the one-way ANOVA test and Tukey’s post-hoc 






C        4          8          12       16       24       48  h  
A. 










































Figure 9. Temporal pattern of HO-1 accumulation in response to 100 μM baicalein. A) Cells 
were maintained at 22 °C (C) or were treated with 100 μM baicalein and harvested after 4, 8, 12, 
16 or 24 h. Proteins were isolated and assessed by immunoblot analysis using anti-HO-1 and 
anti-actin antibodies. B) Densitometric analysis of HO-1 accumulation. The results were 
expressed as % mean relative density compared to maximum density (16 h) as indicated in the 
legend of Figure 3. The error bars indicate standard error of the mean while the significance (p < 
0.05) compared to control was determined by the one-way ANOVA test and Tukey’s post-hoc 



















































Figure 10. Time course of CdCl2-induced HO-1, HSP70 and HSP30 accumulation. A) Cells were 
either maintained at 22 °C (C) or were treated with 200 μM CdCl2 (Cd) and then harvested after 
4, 8, 16 or 24 h. Isolated proteins were subjected to immunoblot analysis as stated in the 
Materials and methods employing anti-HO-1, anti-HSP70, anti-HSP30 and anti-actin antibodies. 
B) Densitometric analysis of HO-1 (black), HSP70 (grey) and HSP30 (white) accumulation. The 
results were expressed as % mean relative density compared to maximum density (HO-1, HSP30 
and HSP70 at 24 h). The error bars indicate standard error of the mean while the significance (p 
< 0.05) compared to control was determined by the one-way ANOVA test and Tukey’s post-hoc 
test and represented by an asterisk. These data are representative of 3 separate experiments. 
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either 25 μM hemin or 100 μM baicalein for 16 h followed by recovery for up to 72 h in fresh 
media. As indicated in Fig. 11, the relative levels of hemin-induced HO-1 gradually declined 
with recovery time to 9% of the levels observed in cells with no recovery. In a similar 
experiment with baicalein, the relative levels of HO-1 declined to a value of 16% at 72 
hcompared to the levels found in baicalein-treated cells with no recovery (Fig. 12). The gradual 
decreases in HO-1 levels during recovery from hemin or baicalein treatment contrasts with 
previous studies in our laboratory showing that cells recovering from CdCl2 displayed a spike in 
HO-1 levels during recovery in fresh media (Music et al., 2014). 
 
3.3 Immunocytochemical analysis of HO-1 and HSP30 localization and actin and tubulin 
cytoskeletal structure in hemin-, baicalein- and CdCl2-treated cells. 
Immunocytochemical analysis was employed to examine the intracellular localization of 
HO-1 in response to hemin, baicalein and CdCl2  treatment (Fig. 13 to 15). In control cells, the 
accumulation of HO-1 was either not detectable or present at relatively low levels. After 10 μM 
hemin treatment, HO-1 was present in the perinuclear region in a punctate pattern with some 
staining in the nucleus (Fig. 13). Cells treated with 25 μM hemin showed a more intense 
accumulation of HO-1 but had a similar cell staining pattern to 10 μM hemin. Similar results 
with respect to HO-1 localization were observed with 100 and 200 μM baicalein as well as 50 
and 100 μM CdCl2  (Fig. 14 and 15). Additionally this pattern of perinuclear HO-1 accumulation 
in a puncate pattern with some staining in the nucleus remained consistent in a series of time 
course experiments from 8 or 12 h to 24 h of treatment with 25 μM hemin, 100 μM baicalein or 
200 μM CdCl2 (Fig. 16-18). While HSP30 was not detected in response to 25 μM hemin or 200 









Figure 11. HO-1 accumulation during recovery from hemin treatment. A) Cells were maintained 
at 22 °C for 16 h (C) or were incubated with media containing 25 μM hemin for 16 h, which was 
then replaced with fresh media. Cells were harvested after incubation in fresh media for 0, 4, 8, 
12, 24, 48 or 72 h at 22 °C. Proteins were isolated and examined by immunoblot analysis using 
anti-HO-1 and anti-actin antibodies. B) Densitometric analysis of HO-1 accumulation. The 
results were expressed as % mean relative density compared to maximal density (0 h recovery) as 
indicated in the legend of Figure 3. The error bars indicate standard error of the mean while the 
significance (p < 0.05) compared to control was determined by the one-way ANOVA test and 
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Figure 12. Temporal pattern of HO-1 accumulation during recovery from baicalein treatment. A) 
Cells were maintained at 22 °C for 16 h (C) or incubated with media containing 100 μM 
baicalein for 16 h followed by replacement with fresh media and incubated at 22 °C. Cells were 
harvested after 0, 24, 48 or 72 h of recovery. Immunoblot analysis using anti-HO-1 and anti-actin 
antibodies was conducted on isolated proteins. B) Densitometric analysis of HO-1 accumulation. 
The results were expressed as % mean relative density (0 h recovery) as indicated in the legend 
of Figure 3. The error bars indicate standard error of the mean while the significance (p < 0.05) 
compared to control was determined by the one-way ANOVA test and Tukey’s post-hoc test and 
represented by an asterisk. These data are representative of 3 separate experiments
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Figure 13. Localization of HO-1 in cells treated with hemin. Cells were cultured on glass 
coverslips for 16 h at 22 °C with either media (C) or media containing 10 or 25 μM hemin (HM). 
Nuclei and actin filaments were stained directly using DAPI (blue) and rhodamine phalloidin 
(red), respectively. HO-1 was detected with an anti-HO-1 antibody and the secondary antibody 
conjugate, Alexa-488 fluorophore (green). White 10 μm scale bars are indicated in the lower 
right corner of each panel. From left to right are columns showing actin, HO-1 and merged 
















Figure 14. Accumulation and distribution of HO-1 in baicalein-treated cells. Cells were cultured 
on glass coverslips for 16 h at 22 °C with either media (C) or media containing 100 or 200 μM 
baicalein (BC). Nuclei and actin filaments were stained directly using DAPI (blue) and 
rhodamine phalloidin (red), respectively. HO-1 was detected with an anti-HO-1 antibody and the 
secondary antibody conjugate, Alexa-488 fluorophore (green). White 10 μm scale bars are 
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Figure 15. HO-1 localization in cells treated with CdCl2. Cells were cultured on glass coverslips 
for 16 h at 22 °C with either media (C) or media containing 50 or 100 μM CdCl2 (Cd). Nuclei 
and actin filaments were stained directly using DAPI (blue) and rhodamine phalloidin (red), 
respectively. HO-1 was detected with the anti-HO-1 antibody and the secondary antibody 
conjugate, Alexa-488 fluorophore (green). White 10 μm scale bars are indicated in the lower 

















Figure 16. Time course of HO-1 localization in cells treated with hemin. Cells were cultured on 
glass coverslips for 16 h at 22 °C with either media (C) or media containing 25 μM hemin for 12, 
16 or 24 h. HO-1 was detected with an anti-HO-1 antibody and the secondary antibody 
conjugate, Alexa-488 fluorophore (green). Actin filaments were stained with rhodamine 
phalloidin (red) and nuclei using DAPI (blue). White 10 μm scale bars are indicated in the lower 














Figure 17. Temporal pattern of HO-1 localization in cells treated with baicalein. Cells were 
cultured on glass coverslips for 16 h at 22 °C with either media (C) or media containing 100 μM 
baicalein for 12, 16 or 24 h. HO-1 was detected with an anti-HO-1 antibody and the secondary 
antibody conjugate, Alexa-488 fluorophore (green). Actin filaments were stained with rhodamine 
phalloidin (red) and nuclei using DAPI (blue). White 10 μm scale bars are indicated in the lower 















Figure 18. Time course of HO-1 localization in cells treated with CdCl2. Cells were cultured on 
glass coverslips for 16 h at 22 °C with either media (C) or media containing 200 μM CdCl2 for 8, 
16 or 24 h. HO-1 was detected with an anti-HO-1 antibody and the secondary antibody 
conjugate, Alexa-488 fluorophore (green). Rhodamine phalloidin (red) and DAPI (blue) were 
used to stain actin filaments and nuclei directly. White 10 μm scale bars are indicated in the 











perinuclear region in a granular fashion with some larger staining structures (indicated with 
white arrows; Fig. 19).  
Actin stress fibres, as detected using phalloidin staining, were generally control-like 
inexperiments using 10 μM hemin or 100 μM baicalein, although a slight disorganization of actin 
filaments was observed with higher concentrations of these agents including 25 μM hemin and 
200 μM baicalein (Fig. 13, 19). Actin fibres were also control-like in cells treated with CdCl2 
concentrations of 100 μM or less (Fig 15). However, treatment of cells with concentrations of 
200 μM CdCl2 resulted in disorganization of actin fibres and membrane ruffling after 12 h (Fig. 
19, 20). Compared to control cells, the microtubule structure, as detected by anti-α-tubulin 
antibody staining, was not markedly affected by 25 μM hemin or by 200 μM baicalein treatment. 
In contrast, treatment of cells with 200 μM CdCl2 resulted in some microtubule network 
disorganization including a coalescence of anti-α-tubulin antibody staining fibres (Fig. 20). 
 
3.4. Effect of transcriptional and translational inhibitors on hemin- and baicalein-induced 
HO-1 accumulation. 
Hemin- and baicalein-induced HO-1 accumulation in A6 cells was the result of de novo 
transcription and translation (Fig. 21). Treatment with 2 or 5 μg/mL of the transcriptional 
inhibitor, actinomycin D, suppressed the 25 μM hemin- or 200 μM baicalein-induced 
accumulation of HO-1 to near control levels with no marked effect on actin levels. Furthermore, 
treatment of cells with 100 μM of the translational inhibitor, cycloheximide, prevented hemin- 
and baicalein-induced accumulation of HO-1. Previous studies in our laboratory have 
demonstrated that CdCl2-induced accumulation of HO-1 was inhibited by actinomycin D or 









Figure 19. Effect of hemin, baicalein or CdCl2 on HSP30 localization of HSP30. Cells were 
cultured on glass coverslips for 16 h at 22 °C. Cells were left untreated (C) or incubated with 25 
μM hemin (HM) 200 μM baicalein (BC) or 200 μM CdCl2 (Cd). Rabbit anti-HSP30 antibody and 
an anti-rabbit antibody conjugated to an Alexa-488 fluorophore were used to detect HSP30 
(green). Nuclei and actin filaments were stained directly using DAPI (blue) and rhodamine 
phalloidin (red), respectively. Large anti-HSP30 staining structures in the perinuclear region are 
indicated with a white arrow. White 10 μm scale bars are indicated in the lower right of each 
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Figure 20. Effect of hemin, baicalein or CdCl2 treatment on the actin and tubulin cytoskeleton. 
Cells were cultured on glass coverslips for 16 h at 22 °C. Cells were left untreated (C) or 
incubated with 25 μM hemin (HM) 200 μM baicalein (BC) or 200 μM CdCl2 (Cd). Alpha-tubulin 
was detected using a mouse anti-α-tubulin antibody and an anti-mouse antibody conjugated to an 
Alexa-488 fluorophore (green). Actin filaments were stained directly using rhodamine phalloidin 
(red) while nuclei were stained with DAPI (blue). White 10 μm scale bars are indicated in the 
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Figure 21. Effect of actinomycin D and cycloheximide on hemin- and baicalein-induced HO-1 
accumulation. A) Cells were maintained at 22 °C (C) or were treated with or without 2 or 5 
μg/ml actinomycin D for 30 min prior to supplementation with 25 μM hemin or 200 μM 
baicalein for 16 h at 22 °C and then harvested. B) Cells were maintained at 22 °C (C) or were 
treated with or without a 6 h pretreatment using 100 μM cycloheximide followed by 
supplementation with 25 μM hemin or 200 μM baicalein for 16 h. After the different sets of 
treatments, proteins were isolated and subjected to immunoblot analysis using anti-HO-1 and 





 -             -             +          + 
Hemin 
CHX B. 
 -             +             -          + 
Actin 
HO-1 
-      -           +        + 





  -             2        5             -          2         5 
Hemin 
Act D (µg/ml) A. 
  -              -         -            +          +         +  
Actin 
HO-1 
   -        2             5             -           2           5 Act D (g/ml) 
     -               -              -            +           +           + Baicalein  
78 
 
3.5. Identification of Nrf2 and HSF1 transcription factor binding sites in the 5' regulatory 
region of the X. laevis ho-1 gene 
In order to help identify possible mechanisms that may be responsible for triggering HO-
1 accumulation in response to hemin or baicalein treatment of A6 cells, putative transcription 
factor binding sites in the 5' regulatory region of X. laevis ho-1 gene were identified using 
Xenbase online sequence data and the Serial Cloner sequence analysis tool (Fig. 22). Two 
potential maf recognition elements (MARE), MARE (1) and MARE (2) were located at -1788 
and -2589, respectively, upstream of the HO-1 transcriptional start site. MARE (1) also had an 
adjacent cadmium-responsive element (CdRE) at -1807. Finally, a heat shock element (HSE) was 
found at position -613 that had a 100% identity to the HSE consensus sequence (Amin et al., 
1988).  
 
3.6 Effect of hemin, baicalein and CdCl2 on Nrf-2 levels in A6 cells   
Since hemin-, baicalein- or CdCl2-induced HO-1 accumulation may be mediated, at least 
in part by Nrf-2, the levels of this transcription factor in response to each of these agents was 
examined by immunoblot analysis (Fig. 23). In cells incubated with 25 μM hemin, no significant 
changes in Nrf-2 levels were detected over a 24 h period (Fig. 23A and B). In contrast, a 
significant increase in Nrf-2 accumulation was detected in 100 μM baicalein-treated cells at 8 h, 
reaching 1.8-fold at 16 h (Fig. 23D). Similarly, treatment with CdCl2 resulted in significantly 
increased amounts of Nrf-2 accumulation at 16 h, with increased levels at 24 h, which were 1.8-








Figure 22. Nrf-2 and HSF1 transcription factor binding sites in the Xenopus laevis ho-1 gene 
promoter region. This schematic of the upstream region of a Xenopus laevis ho-1 gene was 
generated using sequence data obtained from Xenbase (J-strain v 9.1; http://www.xenbase.org/, 
chr4L:107491000..107495999). Putative transcription factor binding sites are represented as 
boxes. The distance from the transcriptional start site to the 5’ and 3’ ends of each binding site 
are denoted at the ends of each box. Percent identity to corresponding elements in the upstream 




















Figure 23. Effect of hemin, baicalein, and CdCl2 on Nrf-2 accumulation. A) Cells were 
maintained at 22 °C for 16 h (C) or were incubated with 25 μM hemin (A, B), 100 μM baicalein 
(C, D) or 200 μM CdCl2 (E, F) and harvested after 4, 8, 16 or 24 h at 22 °C. Isolated proteins 
were analysed by immunoblot using anti-Nrf-2 and anti-actin antibodies. Densitometric analysis 
of Nrf-2 (detected at 66 kDa) accumulation in response to the 3 stressors were carried out. The 
results are expressed as the fold increase relative to the density of the control response. The error 
bars indicate standard error of the mean while the significance (p < 0.05) compared to control 
was determined by the one-way ANOVA test and Tukey’s post-hoc test and represented by an 
asterisk. These data are representative of 3 separate experiments. 
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3.7 Effect of an HSF1 inhibitor, KNK437, on hemin-, baicalein- and CdCl2-induced HO-1 
accumulation.  
Given the finding of an HSE consensus sequence in the 5' regulatory region of the X. laevis ho-1 
gene, it was possible that HSF-1 may be involved in HO-1 induction by hemin, baicalein or 
CdCl2. Therefore, the effect of 100 μM KNK437, an inhibitor of HSF-1 activity, on HO-1 levels 
induced by the 3 stressors was investigated (Fig. 24). In previous studies, KNK437 treatment of 
X. laevis A6 cells inhibited HSP70 and/or HSP30 accumulation induced by a number of stressors 
including heat shock, sodium arsenite, CdCl2, proteasomal inhibitors, and curcumin (Manwell 
and Heikkila, 2007; Voyer and Heikkila, 2008; Woolfson and Heikkila, 2009; Young and 
Heikkila, 2010; Khan and Heikkila, 2011; Khamis and Heikkila, 2013). This concentration of 
KNK437 was reported to inhibit hsp gene expression by inhibiting HSF1-HSE binding activity 
in mammalian and Xenopus cultured cells with no detectable effect on cell viability (Ohnishi et 
al., 2004; Manwell and Heikkila, 2007; Heikkila, 2017). Additionally, similar effects of HSP 
inhibition were reported after treatment of human endothelial or glioma cells with either 
KNK437 or siRNA directed against hsf1 mRNA (Ding et al., 2012; Liu et al., 2012). In the 
present study, treatment of cells with 100 µM KNK437 resulted in a decrease in hemin-, 
baicalein- or CdCl2-induced HO-1 accumulation to very low or undetectable levels. Furthermore, 
KNK437 pretreatment also prevented CdCl2-induced HSP70 accumulation.  
 
3.8 Effect of hemin, baicalein and CdCl2 on PRDX5 accumulation 
The peroxiredoxin 5 (prdx5) gene, which contains an Nrf2 binding site in its promoter 
region, encodes an antioxidant enzyme determined to be ROS stress-inducible in certain cell 








Figure 24. Effect of HSF1 inhibitor, KNK437, on hemin-, baicalein- or CdCl2-induced HO-1 
accumulation. Cells were either maintained at 22 °C (C) or were treated with or without a 6 h 
pretreatment of 100µM KNK437 followed by supplementation with either 25 µM hemin, 100 
µM baicalein or 200 μM CdCl2 for 16 h. Proteins were isolated and analysed by immunoblot 

















Figure 25. Effect of hemin, baicalein, and CdCl2 on PRDX-5 accumulation. Cells were 
maintained at 22 °C for 16 h (Control; C) or were incubated with 25 μM hemin (A, B), 100 μM 
baicalein (C, D) or 200 μM CdCl2 (E, F) and harvested after 4, 8, 16 or 24 h at 22 °C. Isolated 
proteins were analysed by immunoblot using anti-PRDX-5 (detected at 20 kDa) and anti-actin 
antibodies. B) Densitometric analysis of PRDX-5 accumulation. The results are expressed as the 
fold increase of the intensity of the control response. The error bars indicate standard error of the 
mean while the significance compared to control was determined by the one-way ANOVA test 
and Tukey’s post-hoc test and represented by an asterisk (p < 0.05) or triangle (p < 0.1). These 
data are representative of 3 separate experiments.  
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examined in A6 cells treated with 25 μM hemin, 100 μM baicalein or 200 μM CdCl2 (Fig. 25). A 
constitutive amount of PRDX5 was observed in control cells. Relative to control, hemin 
treatment enhanced PRDX5 by 2-fold at 8 h, 1.9-fold at 12 h and 2-fold at 24 h. The levels of 
PRDX5 in baicalein-treated cells increased to 2-fold at 8 h reaching a maximum of 3-fold at 16 h 
followed by a decrease to 2.4-fold at 24 h. Finally, the relative levels of PRDX5 in CdCl2-treated 
cells increased by 1.5-fold at 8 h, decreased to 1.3-fold at 16 h and then to near control-like 
levels at 24 h.   
 
3.9 Detection of ROS generation in hemin, baicalein and CdCl2 treated cells 
Since both HO-1 and PRDX5 have roles in counteracting oxidative stress (Nath et al., 
2000; Yuan et al., 2004), the next phase of this study examined the effect of hemin, baicalein and 
CdCl2 on ROS generation in A6 cells using CellROX green. CellROX green is a molecular probe 
that fluoresces and moves into the nucleus in the presence of elevated levels of ROS. As shown 
in Fig. 26, minimal fluorescence was detected in control cells and in cells treated with 25 μM 
hemin for 4 h. A slight increase in fluorescence was observed with 200 μM baicalein relative to 
control. However, the strongest CellROX fluorescence level of the 3 stressors was observed with 
CdCl2-treated cells. The most pronounced fluorescence was found in cells treated with the 
glutathione synthesis inhibitor, buthionine sulfoxamine (BSO), which was used as a positive 
control.  
 
3.10 Effect of buthionine sulfoxamine (BSO) treatment on hemin, baicalein and CdCl2-
induced HO-1 accumulation 







Figure 26. Effect of hemin, baicalein and CdCl2 on ROS accumulation in A6 cells. Cells were 
cultured on glass coverslips for 4 h with either media (C) or media containing 25 µM hemin 
(HM), 100 µM baicalein (BC), 200 μM CdCl2 (Cd) or 10 mM BSO. ROS generation was 
detected using the CellROX Green reagent (green). Nuclei were stained using DAPI (blue). 
White 10 μm scale bars are indicated in the lower right corner of each panel. These results are 















accumulation could be altered by the oxidative stressor, BSO. In these experiment, cells were 
pretreated with 10 mM BSO for 4 h prior to the addition of 15 μM hemin, 100 μM baicalein or 
50 μM CdCl2 for 16 h. Immunoblot analysis was used to detect HO-1 and the ROS-inducible 
enzyme, superoxide dismutase 1 (SOD1). BSO treatment did not induce elevated levels of HO-1 
but did induce SOD1 accumulation (Fig. 27). Also 15 μM hemin treatment enhanced both HO-1 
and SOD1 levels compared to control. However, treatment with BSO prior to supplementation 
with hemin did not induce levels of HO-1 or SOD1 that were greater than found with hemin 
alone. While exposure of cells to 100 μM baicalein induced elevated levels of both HO-1 and 
SOD1, BSO and baicalein treatment did not affect the amount of HO-1 but did reduce the levels 
of SOD1 to control levels (Fig. 28). Finally, treatment of A6 cells with 25 μM CdCl2 induced 
elevated levels of both HO-1 and SOD1 relative to control (Fig. 29). However, in contrast to 
hemin and baicalein, treatment of cells with BSO prior to augmentation with CdCl2 enhanced the 
relative levels of HO-1 compared to BSO or CdCl2 alone. In this latter treatment regimen, SOD1 
levels were comparable to those found in cells treated with BSO or CdCl2 alone.  
 
3.11 Effect of hemin, baicalein and CdCl2 on the accumulation of aggregated protein and 
aggresome-like structures  
In the previous experiments, it was found that treatment of A6 cells with either 25 μM 
hemin, 100 μM baicalein or 200 μM CdCl2 enhanced the relative levels of SOD1 and PRDX5. 
Furthermore, CELLROX analyses determined that CdCl2 and to a lesser extent, baicalein, 
increased the presence of ROS in these cells. Also, other studies reported that reactive oxygen 
species have the potential to alter protein structure, which could possibly lead to their 








Figure 27. Effect of BSO treatment on hemin-induced HO-1 and SOD1 accumulation. A) Cells 
were maintained at 22 °C for 16 h (C) or were incubated with or without a 4 h treatment with 10 
mM BSO followed by supplementation with 15 μM hemin for 16 h. Isolated proteins were 
examined by immunoblot analysis using anti-HO-1, anti-SOD1 (detected at 15 kDa) and anti-
actin antibodies. B) Densitometric analysis of HO-1 or SOD1 accumulation. The results were 
expressed as % mean relative density compared to the maximum density (10 mM BSO and 15 
μM hemin for both HO-1 and SOD1) as indicated in the legend of Figure 3. The error bars 
indicate standard error of the mean while the significance (p < 0.05) compared to control was 
determined by the one-way ANOVA test and Tukey’s post-hoc test and represented by an 
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Figure 28. Influence of BSO treatment on baicalein-induced HO-1 and SOD1 accumulation. A) 
Cells were maintained at 22 °C for 16 h (C) or were incubated with or without a 4 h treatment 
with 10 mM BSO followed by augmentation with 100 µM baicalein for 16 h. Isolated proteins 
were assessed by immunoblot analysis using anti-HO-1, anti-SOD1 and anti-actin antibodies. B) 
Densitometric analysis of HO-1 or SOD1 accumulation. The results were expressed as % mean 
relative density compared to maximum density (10 mM BSO for HO-1 and 100 μM baicalein for 
HO-1) as indicated in the legend of Figure 3. The error bars indicate standard error of the mean 
while the significance (p < 0.05) compared to control was determined by the one-way ANOVA 
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Figure 29. Effect of BSO treatment on CdCl2-induced HO-1 and SOD1 accumulation. A) Cells 
were maintained at 22 °C for 16 h (C) or were incubated with or without a 4 h treatment with 10 
mM BSO followed by supplementation with 25 µM CdCl2 for 16 h. Isolated proteins were 
examined by immunoblot analysis using anti-HO-1, anti-SOD1 and anti-actin antibodies. B) 
Densitometric analysis of HO-1 or SOD1 accumulation. The results were expressed as % mean 
relative density compared to maximum density (10 mM BSO plus 25 μM baicalein for HO-1 and 
SOD1) as indicated in the legend of Figure 3. The error bars indicate standard error of the mean 
while the significance (p < 0.05) compared to control was determined by the one-way ANOVA 
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employed a Proteostat dye to investigate the presence of aggregated protein or aggresome-like 
structures in A6 cells treated with hemin, baicalein or CdCl2 (Khan et al., 2015; Shirriff and 
Heikkila, 2017; Khamis and Heikkila, 2018). As demonstrated in Fig. 30, Proteostat staining was 
minimal in control cells as well as in cells treated with 25 μM hemin or 200 μM baicalein. 
However, incubation with 200 μM CdCl2 resulted in the accumulation of aggregated protein 
primarily in the perinuclear region in a granular fashion. Large aggresome-like structures, as 
indicated by white arrows, were also detected in 200 μM CdCl2-treated cells. CdCl2-induced 
aggresome-like structures were previously reported in X. laevis A6 cells and human embryonic 
kidney cells (Song et al., 2008; Khan et al., 2015). Finally, the microtubular structure, as detected 
by an anti-α-tubulin antibody, in hemin- and baicalein-treated cells resembled control cells 
whereas microtubules in CdCl2-treated cells displayed areas of disorganization. 
 
3.12 Effect of HO-1 enzyme activity inhibitors, SnPP and ZnPP, on the accumulation HO-1 
in CdCl2-treated A6 cells.  
This study also examined the effect of inhibiting HO-1 enzyme activity on CdCl2-induced 
accumulation of HO-1. Two inhibitors of HO-1 enzyme activity, zinc protoporphyrin (ZnPP) and 
tin protoporphyrin (SnPP), were employed (Drummond and Kappas 1981; Srisook et al., 2005). 
Initial analyses determined that treatment of cells with 5 or 7.5 μM ZnPP induced a slight 
enhancement of HO-1 levels compared to control whereas treatment with 5, 15 or 25 μM had no 
effect (Fig. 31). The presence of either 5 μM ZnPP or 15 μM SnPP enhanced CdCl2-induced 
accumulation of HO-1 compared to 50 μM CdCl2 alone (Fig. 32). Densitometric analysis 
determined that the relative level of HO-1 found with SnPP alone was comparable to control 








Figure 30. Effect of hemin, baicalein and CdCl2 on the accumulation of aggregated protein and 
aggresome-like structures. Cells were cultured on glass coverslips for 16 h at 22 °C. Cells were 
left untreated (C) or incubated with 25 μM hemin (HM), 200 μM baicalein (BC) or 200 µM 
CdCl2 (Cd). Alpha-tubulin was detected using a mouse anti-α-tubulin antibody and an anti-
mouse antibody conjugated to an Alexa-488 fluorophore (green). Aggregated protein and 
aggresome-like structures were detected using the Proteostat dye (red). Nuclei are stained with 
DAPI (blue). White arrows indicate the presence of aggresome-like structures. White 10 μm 
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Figure 31. Effect of ZnPP and SnPP on HO-1 accumulation. A) Cells were maintained at 22 °C 
(C) or treated with 2.5, 5, or 7.5 μM of ZnPP or 5, 15, or 25 μM of SnPP or 25 μM hemin for 16 
h at 22 °C. Hemin was used as a positive control since it induced accumulation of HO-1. 
Immunoblot analysis of isolated proteins employed anti-HO-1 and anti-actin antibodies. B) 
Densitometric analysis of HO-1 accumulation. The results were expressed as % mean relative 
density as indicated in the legend of Figure 3. The error bars indicate standard error of the mean 
while the significance (p < 0.05) compared to control was determined by the one-way ANOVA 













































Figure 32. Effect of ZnPP or SnPP treatment on 50 µM CdCl2-induced HO-1 and HSP70 
accumulation. A) Cells were maintained at 22 °C (C) or treated with or without a 5 μM ZnPP or 
15 μM SnPP 4 h treatment prior to supplementation with 50 µM CdCl2 for 16 h at 22 °C. 
Immunoblot analysis of isolated proteins employed anti-HO-1, anti HSP70 and anti-actin 
antibodies. B) Densitometric analysis of HO-1 (black bars) and HSP70 (grey bars) 
accumulation. The results were expressed as % mean relative density as indicated in the legend 
of Figure 3. The error bars indicate standard error of the mean while the significance (p < 0.05) 
compared to control was determined by the one-way ANOVA test and Tukey’s post-hoc test and 
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levels whereas the mean relative density of SnPP plus CdCl2 was 90%. Finally, while the HO-1 
enzyme activity inhibitors did not induce detectable HSP70 accumulation and 50 μM CdCl2 
induced only a slight increase in HSP70 levels relative to control, treatment with either ZnPP or 
SnPP plus CdCl2 resulted in mean relative density values of 56% and 100%, respectively. 
 
3.13 Effect of HO-1 enzyme activity inhibitors on CdCl2-induced HO-1 localization, actin 
and tubulin cytoskeletal structure and the presence of aggregated protein.  
Since treatment of A6 cells with HO-1 enzyme activity inhibitors enhanced CdCl2-
induced HO-1 and HSP70 accumulation, it was of interest to determine whether ZnPP or SnPP 
had an effect on CdCl2-induced HO-1 localization, cytoskeletal structure and the production of 
aggregated protein. As revealed in Fig. 33, treatment with either 5 μM ZnPP or 15 μM SnPP 
prior to augmentation with 100 μM CdCl2 enhanced the accumulation of HO-1 in the perinuclear 
region with some staining in the nucleus compared to cells incubated with CdCl2 or the HO-1 
enzyme activity inhibitors alone. As shown in Fig. 33 and 34, actin stress fibres and the pattern 
of microtubules in cells treated with ZnPP, SnPP or 100 μM CdCl2 resembled those of control 
cells. In cells treated with either ZnPP or SnPP prior to supplementation with CdCl2, there was 
noticeable membrane ruffling and disorganization of the actin cytoskeleton. The effect of ZnPP 
plus CdCl2 exposure on the microtubule network was characterized by a reduction in anti-α-
tubulin antibody staining in the perinuclear region and a mesh-like appearance throughout the 
cytoplasm compared to control cells. In cells treated with SnPP prior to the addition of CdCl2, 
tubulin filaments appeared to be more tangled or intertwined than found in control.  
 The HO-1 enzyme activity inhibitors also enhanced the 100 μM CdCl2-induced 









Figure 33. Effect of ZnPP or SnPP treatment on CdCl2-induced HO-1 localization. Cells were 
cultured on glass coverslips for 16 h at 22 °C. Cells were left untreated (C) or incubated with 100 
µM CdCl2 (Cd) for 16 h. In other experiments, cells were treated for 4 h with either 5 μM ZnPP 
(panel A) or 15 μM SnPP (panel B) and then supplemented with 100 μM CdCl2 for 16 h. Nuclei 
and actin filaments were stained directly using DAPI (blue) and rhodamine phalloidin (red), 
respectively. HO-1 was detected with an anti-HO-1 antibody and the secondary antibody 
conjugate, Alexa-488 fluorophore (green). White 10 μm scale bars are indicated in the lower 






























Figure 34. Effect of ZnPP or SnPP treatment on actin and tubulin organization. Cells were 
cultured on glass coverslips for 16 h at 22 °C. Cells were left untreated (C) or incubated with 100 
µM CdCl2 (Cd) for 16 h. In other experiments, cells were treated for 4 h with either 5 μM ZnPP 
(panel A) or 15 μM SnPP (panel B) and then supplemented with 100 μM CdCl2 for 16 h. Nuclei 
and actin filaments were stained directly using DAPI (blue) and rhodamine phalloidin (red), 
respectively. Alpha-tubulin was detected using a mouse anti-α-tubulin antibody and an anti-
mouse antibody conjugated to an Alexa-488 fluorophore (green). White 10 μm scale bars are 





























Figure 35. Effect of ZnPP or SnPP treatment on CdCl2-induced aggregated protein and 
aggresome-like structure formation. Cells were left untreated (C) or incubated with 100 µM 
CdCl2 (Cd) for 16 h. In other experiments, cells were treated for 4 h with either 5 μM ZnPP or 15 
μM SnPP and then supplemented with 100 μM CdCl2 for 16 h. Alpha-tubulin was detected using 
a mouse anti-α-tubulin antibody and an anti-mouse antibody conjugated to an Alexa-488 
fluorophore (green). Aggregated protein and aggresome-like structures were detected using the 
Proteostat dye (red).Nuclei are stained with DAPI (blue). White arrows indicate the presence of 
aggresome-like structures. White 10 μm scale bars are indicated in the lower right of each panel. 
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with 5 μM ZnPP or 15 μM SnPP resulted in minimal accumulation of aggregated protein that 
was similar to control cells as determined by Proteostat dye staining. An increase in aggregated 
protein in the perinuclear region was detected in cells treated with 100 μM CdCl2. However, this 
accumulation of aggregated protein was enhanced in cells treated with ZnPP or SnPP prior to 
supplementation with CdCl2. Furthermore, these cells were characterized by the presence of 
larger, aggresome-like staining structures, as indicated by white arrows.  
 
3.14 Effect of hemin and baicalein treatment on CdCl2-induced changes to actin 
cytoskeletal structure and the accumulation of aggregated protein.  
 Previous studies reported that treatment of cells with hemin or baicalein have the 
potential to ameliorate the deleterious effects of potentially toxic conditions including CdCl2 
exposure (Salahudeen et al., 2001; Gozzelino et al., 2010; Cui et al., 2015). Furthermore, studies 
in mammalian cells have shown that pretreatment with hemin also protected cells against 
injurious levels of CdCl2 (Srisook et al., 2005; Fouad et al., 2009). The next section of the 
present study investigated the ability of low levels of hemin or baicalein to protect A6 cells from 
relatively high concentrations of CdCl2 (Fig. 36 & 37). Initial experiments examined the effect of 
a 4 h 10 μM hemin treatment followed by supplementation with 275 μM CdCl2 for 16 h and a 
subsequent 4 h recovery in fresh media on actin cytoskeleton and HO-1 accumulation. As 
revealed in Fig. 36, treatment of cells with 10 μM hemin for 16 h had no discernable effect on 
the actin cytoskeleton whereas exposure of cells to 275 μM CdCl2 resulted in actin cytoskeletal 
disorganization, cell rounding and membrane ruffling. However, treatment of cells with hemin 
prior to the addition of CdCl2 resulted in the presence of control-like actin stress fibres although 








Figure 36. Effect of treatment with hemin and/or SnPP on Cd-induced HO-1 localization and 
actin organization. Cells were left untreated (C) or incubated with 275 µM CdCl2 (Cd) for 16 h at 
22 °C. In other experiments cells were treated for 4 h with 10 μM hemin (HM) and/or 15 μM 
SnPP prior to being supplemented with 275 µM CdCl2. Nuclei and actin filaments were stained 
directly using DAPI (blue) and rhodamine phalloidin (red), respectively. HO-1 was detected with 
an anti-HO-1 antibody and the secondary antibody conjugate, Alexa-488 fluorophore (green). 
White 10 μm scale bars are indicated in the lower right of each panel. These data are 
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Figure 37. Effect of treatment with baicalein and/or SnPP on Cd-induced HO-1 localization and 
actin organization. Cells were left untreated (C) or incubated for 16 h with 275 µM CdCl2 (Cd) 
followed by a 4 h recovery in fresh media. In other experiments, cells were treated for 4 h with 
50 μM baicalein (BC) and/or 15 μM SnPP before supplementation with 275 µM CdCl2 followed 
by a 4 h recovery in fresh media. Nuclei and actin filaments were stained directly using DAPI 
(blue) and rhodamine phalloidin (red), respectively. HO-1 was detected with an anti-HO-1 
antibody and the secondary antibody conjugate, Alexa-488 fluorophore (green). White 10 μm 
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treated cells resulted in a pattern of actin distribution similar to that found with hemin alone. 
Cells treated with CdCl2 and SnPP without hemin also showed a severe disruption of the actin 
cytoskeleton. As shown in Fig. 37, exposure of cells to 50 μM baicalein prior to augmentation 
with 275 μM CdCl2 resulted in the presence of actin stress fibres and a cell shape that was similar 
to control although some membrane ruffling was detected. Exposure of cells to SnPP and hemin 
treatment followed by the addition of CdCl2 also resulted in an actin cytoskeleton that was 
similar to CdCl2 alone, including cell rounding, membrane ruffling and cytoskeletal collapse. 
Additionally, abundant amounts of HO-1 were observed in the perinuclear region of cells 
pretreated with hemin or baicalein prior to the addition of CdCl2 in contrast to lower levels of 
HO-1 found with hemin, CdCl2 or SnPP alone (Fig. 36 and 37). 
 The effect of hemin or baicalein treatment prior to the addition of CdCl2 on the levels of 
aggregated protein accumulation are shown in Fig. 38 and 39. Treatment of cells with 275 μM 
CdCl2 resulted in the perinuclear accumulation of aggregated protein as well as the presence of 
large aggresome-like staining structures. Exposure of cells to 10 μM hemin or 50 μM baicalein 
followed by supplementation with CdCl2 resulted in diminished amounts of both diffuse and 
perinuclear aggregated protein and aggresome-like staining structures. However, if cells were 
treated with SnPP and hemin or baicalein prior to the addition of CdCl2, aggregated protein and 
aggresome-like structures were observed. In an examination of microtubule structure, treatment 
with 275 μM CdCl2 resulted in some disorganization and intertwining of microtubules. This 
effect was mitigated in cells treated with hemin prior to CdCl2 addition as they had more 
elongated, parallel microtubules compared to CdCl2 alone. In cells that were treated with SnPP 








Figure 38. Effect of treatment with hemin and/or SnPP on Cd-induced aggregated protein and 
microtubular network. Cells were left untreated (C) or incubated with 275 µM CdCl2 (Cd) for 16 
h. Other treatments included incubation of cells with 10 μM hemin (HM) and/or 15 μM SnPP for 
4 h prior to supplementation with 275 µM CdCl2 for 16 h followed by a 4 h recovery in fresh 
media. Alpha-tubulin was detected using a mouse anti-α-tubulin antibody and an anti-mouse 
antibody conjugated to an Alexa-488 fluorophore (green). Aggregated protein and aggresome-
like structures was detected by use of the Proteostat dye (red).Nuclei are stained with DAPI 
(blue). White arrows indicate the presence of aggresome-like structures. White 10 μm scale bars 
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Figure 39. Effect of treatment with baicalein and/or SnPP on Cd-induced aggregated protein and 
microtubular network. Cells were left untreated (C) or incubated with 275 µM CdCl2 (Cd) for 16 
h. Other treatments included incubation of cells with 50 μM baicalein (BC) and/or 15 μM SnPP 
for 4 h prior to supplementation with 275 µM CdCl2 for 16 h followed by a 4 h recovery in fresh 
media. Alpha-tubulin was detected using a mouse anti-α-tubulin antibody and an anti-mouse 
antibody conjugated to an Alexa-488 fluorophore (green). Aggregated protein and aggresome-
like structures were detected using the Proteostat dye (red). Nuclei are stained with DAPI (blue).  
White arrows indicate aggresome-like structures. White 10 μm scale bars are indicated in the 
lower right of each panel. These data are representative of 3 separate trials. 
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3.15 Effect of hemin, baicalein and SnPP treatment on the localization of CdCl2-induced 
HSP30 and aggregated protein accumulation. 
 Previously, our laboratory reported that CdCl2-induced aggresome-like structures that co-
localized with the small HSP, HSP30 (Khan et al., 2015). Given these earlier results, HSP30 
localization was examined in the current study (Fig. 40). In cells treated with CdCl2 alone, 
HSP30 accumulated in a punctate pattern with larger staining structures, as indicated by the 
white arrows. These larger anti-HSP30 antibody stained structures co-localized with the 
aggresome-like structures (detected by the Proteostat dye), given their yellow colour in the 
merged channel. This finding was verified by means of Z-stack analysis (data not shown). In 
cells treated with hemin prior to supplementation with CdCl2, the amount of aggregated protein 
was reduced compared to CdCl2 alone whereas the amount of HSP30 accumulation in some cells 
was elevated and had a more diffuse pattern of cytoplasmic distribution and fewer larger 
structures. Addition of SnPP plus hemin prior to CdCl2 treatment resulted in cells having a 
pattern of HSP30 accumulation that resembled CdCl2 alone. The accumulation of HSP30 and 
aggregated protein was also investigated in cells that were treated with baicalein and CdCl2 (Fig. 
41). Treatment with baicalein followed by supplementation with CdCl2 reduced the intensity of 
Proteostat dye staining as well as the lower number of larger-aggresome structures compared to 
what was found in CdCl2-treated cells. However, HSP30 levels were elevated in baicalein and 
CdCl2-supplemented cells compared to cells treated with CdCl2 alone. As with hemin treatment, 
exposure of cells to baicalein resulted in a diffuse cytoplasmic pattern of HSP30 accumulation 
with enrichment in the perinuclear region and fewer aggresome-like structures, compared to 
CdCl2 treatment alone, that co-localized with HSP30 as determined by Z-stack analysis (data not 







Figure 40. Effect of treatment with hemin and SnPP on Cd-induced HSP30 and aggregated 
protein and aggresome-like structures. Cells were left untreated (C) or incubated with 275 µM 
CdCl2 (Cd) for 16 h. Other treatments included incubation of cells with 10 μM hemin (HM) 
and/or 15 μM SnPP for 4 h prior to supplementation with 275 µM CdCl2 for 16 h followed by a 4 
h recovery in fresh media. Rabbit anti-HSP30 antibody and an anti-rabbit antibody conjugated to 
an Alexa-488 fluorophore were used to detect HSP30 (green). Aggregated protein and 
aggresome-like structures (white arrows) was detected by means of the Proteostat dye (red). 
Nuclei are stained with DAPI (blue).  White 10 μm scale bars are indicated in the lower right of 
each panel. These data are representative of 3 separate experiments. 
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Figure 41. Effect of treatment with baicalein and SnPP on Cd-induced HSP30 and aggregated 
protein and aggresome-like structure accumulation. Cells were left untreated (C) or incubated 
with 275 µM CdCl2 (Cd) for 16 h. Other treatments included incubation of cells with 50 μM 
baicalein (BC) and/or 15 μM SnPP for 4 h prior to supplementation with 275 µM CdCl2 for 16 h 
followed by a 4 h recovery in fresh media. Rabbit anti-HSP30 antibody and an anti-rabbit 
antibody conjugated to an Alexa-488 fluorophore were used to detect HSP30 (green). 
Aggregated protein and aggresome-like structures were detected using Proteostat dye (red). 
Nuclei are stained with DAPI (blue). White arrows indicate aggresome-like structures. White 10 




Proteostat HSP30 Merge 
50 µM  
BC +  
275 µM  




275 µM  
Cd 
50 µM  
BC +  




in a pattern of HSP30 accumulation, which resembled that of CdCl2 alone.
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4.0 Discussion   
This study has described for the first time, in Xenopus laevis, the effects of hemin and 
baicalein on HO-1 accumulation. Furthermore, hemin and baicalein treatment of A6 kidney 
epithelial cells conferred cytoprotection against a CdCl2 stress challenge, which was assessed by 
the maintenance of the actin cytoskeleton and an inhibition in the accumulation of aggregated 
protein and aggresome-like structures. HO-1 enzyme activity inhibitor treatment determined that 
HO-1 accumulation was vital in cytoprotection in response to CdCl2 treatment. 
Analysis of the X. laevis HO-1 amino acid sequence determined that it shared 91% 
sequence identity with X. tropicalis HO-1 but only 50 to 64% identity with bird, fish, reptile, and 
mammalian HO-1 or constitutive human or X. laevis HO-2. In general, the present findings were 
in agreement with previous studies of X. laevis HO-1 amino acid sequence (Music et al., 2014). 
However, a more detailed comparison of the amino acid sequence alignment of X. laevis and H. 
sapiens HO-1 amino acid sequences revealed a 100% shared identity in residues that were 
important for heme binding including a histidine involved in iron binding, which is essential for 
its catalytic function (Schuller et al., 1999). Another highly conserved feature of Xenopus and 
human HO-1 is a 24 amino acid HO-1 signature domain starting at P189 in Xenopus (Maines and 
Gibbs, 2005). In this region, X. laevis and H. sapiens sequence identity was 95% (23 out of 24 
amino acids). Conservation was lower in other regions of HO-1, specifically near the N- and C-
terminus and the flexible linker region. It was reported that goldfish HO-1 had a similar pattern 
of conservation, with high amino acid identity with other species in the core catalytic region and 
greater variability in the N-terminal, C-terminal helix and the flexible linker regions (Wang et al., 
2008). Computer model predictions of X. laevis and H. sapiens HO-1 indicated that both proteins 
have similar secondary structure in the heme-binding site region. Furthermore, the similarity 
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between the computer models suggested that the non-conserved regions of X. laevis HO-1 were 
not radically different from H. sapiens as to affect the overall theoretical structure of the protein. 
This finding suggested that the X. laevis and human HO-1 may have a similar catalytic 
mechanism.  
Initial immunoblot studies determined that hemin-induced HO-1 accumulation in A6 cells 
was concentration- and time-dependent. For example, hemin induced elevated HO-1 levels 
compared to control at 10 μM hemin with a peak at 25 μM. Also, continuous treatment of cells 
with 25 μM hemin induced transient accumulation of HO-1, which peaked at 12 h followed by a 
gradual reduction from 16 to 48 h. In other studies, hemin concentrations ranging from 2.5 to 20 
μM were employed to induce the accumulation of ho-1 mRNA or encoded protein in rat glioma, 
human kidney and HeLa cells as well as in human monocytes (Shibahara, 1987; Masuya et al., 
1998; Salahudeen et al., 2001; Lang et al., 2004). In human monocytes, hemin-induced 
accumulation of HO-1 mRNA was dose-dependent while the accumulation of HO-1 protein was 
transient showing elevated levels at 12 h, maximal amounts at 24 h followed by a reduction at 48 
h (Lang et al., 2004).  
Baicalein-induced HO-1 accumulation in A6 cells was also dose-dependent with 
detectable amounts at 50 μM and peak levels at 200 μM. As found with hemin, continuous 
baicalein treatment also induced a transient increase in HO-1 levels with maximal amounts at 16 
h and reduced levels at 24 h. In rat C6 glial cells, a dose-dependent increase in HO-1 was 
reported after baicalein treatment using concentrations ranging from 25 to 200 μM (Chen et al., 
2006). Choi et al. (2016) also reported a time-dependent accumulation in response to baicalein in 
glial cells from 1 to 6 h (their final time point). Dose-dependent (12.5 to 200 μM) and time-
dependent (4 to 12 h) increases in baicalein-induced HO-1 accumulation were also reported with 
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mouse macrophages and rat adrenal pheochromocytoma cells (Lin et al., 2007; Zhang et al., 
2012). The results of the present research in X. laevis cells indicate that treatment with hemin or 
baicalein induced a dose- and temperature-dependent accumulation of HO-1 as reported in 
mammalian cultured cells.  
Additionally, this study determined that CdCl2-induced HO-1 accumulation occurred in a 
concentration- and time-dependent manner in A6 cells. For example, treatment with 25 μM 
CdCl2 was sufficient to cause a detectable increase in the amount of HO-1, with maximum 
accumulation observed after treatment with 200 μM CdCl2. Accumulation of HO-1 was 
detectable at 8 h of treatment with 200 μM CdCl2 before reaching its maximum level at 24 h. 
These results are supported by previous analyses in our laboratory regarding CdCl2-induced 
enhancement of HO-1 in A6 cells (Music et al., 2014). Induction of HO-1 by cadmium has been 
documented across a wide range of organisms. In Atlantic cod cell cultures, an increase in HO-1 
accumulation occurred after 24 h of treatment with 100 μM CdCl2 (Søfteland et al., 2010). In 
mouse hepatoma cells, HO-1 mRNA was detected after 4 h of treatment with 2.5 μM CdCl2 
while in chicken liver cells, an increase in heme oxygenase activity was detected after 
administration of 2 μM CdCl2 (Sardana et al., 1982; Alam et al., 1989). Also, HO-1 mRNA was 
detected in human leukemia cells treated with 10 μM CdCl2 after 8 h (Taketani et al., 1989). 
Finally, an increase in HO-1 mRNA occurred in soybean root nodules 48 h after exposure to 200 
μM CdCl2 (Balestrasse et al., 2008). The present study found that CdCl2 treatment of X. laevis 
cells also induced the accumulation of HSP70 and HSP30. Studies in our laboratory reported that 
CdCl2 was capable of inducing the heat shock response in A6 cells leading to the accumulation 
of HSP30 and HSP70 (Woolfson and Heikkila, 2009; Khamis and Heikkila, 2013; Khan et al., 
2015; Shirriff and Heikkila, 2017). Furthermore, previous findings indicated that treatment with 
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the HSF1 inhibitor, KNK437, inhibited CdCl2-induced HSP30 and HSP70 accumulation (Voyer 
and Heikkila, 2008; Khamis and Heikkila, 201). It was suggested that CdCl2 treatment of cells 
can cause an increase in unfolded proteins through either oxidative damage or by the formation 
of polydentate coordination complexes with the protein backbone (Galazyn-Sidorczuk et al., 
2009; Tamás et al., 2014). The accumulation of unfolded protein then acts as a trigger for HSF1 
activation leading to the expression of hsp genes in an attempt to counteract the formation of 
toxic protein aggregates (Westerheide and Morimoto, 2005; Morimoto 2008).   
The inhibition of hemin- or baicalein-induced HO-1 accumulation in response to 
actinomycin D or cycloheximide treatment indicated that HO-1 accumulation was the 
consequence of de novo transcription and translation. Analysis of the promoter region upstream 
of the X. laevis ho-1 transcriptional start site revealed key cis-acting promoter elements that may 
be involved in stress-induced ho-1 gene expression. As in humans and mice, the X. laevis ho-1 
promoter possesses multiple MARE sequences, suggesting the involvement of the transcription 
factors, Nrf-2/Keap1 and Bach1 in ho-1 gene expression. Previous reports from our laboratory 
speculated that CdCl2 induction of HO-1 was due to the generation of ROS and disruption of 
Nrf-2/Keap1 association causing Nrf-2 stabilization (Fig. 42; Music et al., 2014). However, 
hemin- or baicalein-induced accumulation may rely on an alternate mechanism. As shown in this 
study, hemin treatment did not promote an increase in Nrf-2 levels. In other organisms, it was 
reported that heme was capable of directly binding to the repressor protein, Bach1, which caused 
it to detach from the MARE site, thus permitting the binding of Nrf-2. Therefore, it is likely that 
hemin treatment of A6 cells resulted in an inhibition of Bach1 repression and that constitutive 
levels of Nrf-2 were sufficient to bind to the MARE site and cause HO-1 transcription (Fig. 42). 






Figure 42. Induction of ho-1 gene expression induction by hemin, baicalein or cadmium. A) 
Treatment with hemin increases intracellular heme levels (1). Increased heme binds to Bach1 (2), 
causing its export from the nucleus and degradation (3). This frees the MARE element and 
permits binding by low levels of Nrf2 (4). While HSF involvement in hemin-induced HO-1 
accumulation was indicated by KNK437 experiments, the exact mechanism of HSF involvement 
remains undetermined although it may bind to the HSE or to CdRE either alone or bound to 
Pescadillo (5). B) Baicalein disrupts Nrf2-Keap1 interactions by binding to Keap1 (1). This 
results in increased Nrf2 stabilization and accumulation (2) permitting it to bind to MARE and 
initiating ho-1 gene expression (3). As stated earlier, partial inhibition of Bach1 repression by 
endogenous heme is sufficient to allow for HO-1 expression (4). HSF may be involved in 
baicalein-induced HO-1 accumulation as mentioned above (5). C) Cadmium, either through 
increased ROS generation or modification of cysteine residues of Keap1 (1), disrupts the Keap1-
Nrf2 interaction (2). This results in an increase in Nrf2 stabilization and accumulation allowing it 
to bind to MARE resulting in ho-1 gene expression (3). Partial inhibition of Bach1 repression by 
endogenous heme is sufficient to allow ho-1 gene expression (4). HSF involvement in ho-1 gene 
expression may occur via binding to HSE or to CdRE alone or complexed with Pescadillo (5). 
Cadmium exposure also causes an increase in unfolded proteins either directly or via ROS 
generation (6). Unfolded protein accumulation results in HSF activation (7) and the hsp gene 












only a slight increase in ROS levels compared to CdCl2 treatment. Other studies suggested that 
baicalein may directly modify cysteine residues on Keap-1 causing its disassociation from Nrf-2 
resulting in increased Nrf-2 stabilization (Zhang et al., 2012, Cui et al., 2015). This explanation 
is consistent with the present study, in which baicalein treatment increased Nrf-2 levels and a 
mild level of oxidative stress (Fig. 42). However, further studies will be required to verify this 
possible mechanism.    
In X. laevis cells, the HSF1 DNA binding inhibitor, KNK437, inhibited the accumulation 
of HO-1 in response to hemin, baicalein or CdCl2 treatment. Furthermore, DNA sequence 
analysis determined that the promoter region of the X. laevis ho-1 gene has CdRE and HSE 
elements. As mentioned in the introduction, these elements were capable of binding HSF1 
although these events were not sufficient by themselves to induce ho-1 gene expression in HeLa 
cells (Koizumi et al., 2007). Also, the possibility that HSF1 activation by hemin or baicalein was 
necessary for HO-1 accumulation was not supported by the finding that treatment with these 
agents did not induce a detectable increase in either HSP70 or HSP30. Also, earlier studies 
reported that HO-1 accumulation was not heat shock-inducible in X. laevis A6 cells and in a 
variety of human cell lines, including alveolar macrophages, hepatoma, glioma, fibroblast and 
others (Yoshida et al., 1988; Keyse and Tyrrell, 1989; Taketani et al., 1989; Mitani et al., 1990; 
Okinaga et al., 1996; Music et al., 2014). It has been suggested that the involvement of HSF1 in 
HO-1 induction may be indirect, possibly acting in conjunction with another transcription factor, 
such as pescadillo (Sikorski et al., 2006). In this latter study, pescadillo interacted with the CdRE 
in the ho-1 promoter and that overexpression of pescadillo increased HO-1 accumulation in 
human kidney cells. The possibility of pescadillo and HSF1 acting in concert was proposed in a 
study that identified HSF1/CdRE binding involvement in ho-1 gene expression but noted that 
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HSF1 activation alone was not sufficient to result in transcription of CdRE containing genes 
(Koizumi, 2007). Another possibility was the involvement of an alternative HSF family member 
in HO-1 activation. It was reported that hemin treatment resulted in an increase in HSF2 binding 
to promoter regions in human leukemia cells (Sistonen et al., 1992). Further studies using 
leukemia cells showed by means of chromatin immunoprecipitation that HSF2 binding was 
activated by hemin but not heat shock (Trinklein et al., 2004). It has also been shown that HSF2 
can interact with HSEs as a heterooligomer with HSF1 (Östling et al., 2007). Thus, it is possible 
that KNK437 may have an inhibitory effect on HSF2 or that it can inhibit HSF1-HSF2 
complexes by acting on HSF1. Further research on the effects of hemin and baicalein on HSF1, 
HSF2 and possible interacting partners like pescadillo is necessary to fully understand HO-1 
induction in response to hemin, baicalein or CdCl2.  
The subcellular localization of HO-1 in hemin-, baicalein- and CdCl2-treated A6 cells 
was consistently perinuclear in a punctate pattern. Previously, our laboratory found a similar 
perinuclear localization of HO-1 in A6 cells treated with CdCl2, sodium arsenite, MG132 or 
isothiocyanates (Music et al, 2014; Khamis and Heikkila, 2018). The present finding was also in 
agreement with mammalian studies, which reported that HO-1, which lacks an ER target 
sequence, was anchored to the ER by a C-terminal transmembrane region such that it faced the 
cytosol (Yoshida and Sato, 1989; Gottlieb et al., 2012). In some A6 cells, it was determined that 
hemin, baicalein or CdCl2 treatment resulted in HO-1 accumulation in the nucleus. The 
appearance of HO-1 in nuclei was reported in a number of mammalian tumour cells or in cells 
subjected to hypoxia stress (Converso et al., 2006; Slebos et al., 2007; Lin et al., 2007; Gandini 
et al., 2012; Namba et al., 2014). Studies in mammalian cells determined that HO-1 could be 
cleaved from its ER anchor and undergo translocation to the nucleus (Lin et al., 2007; Sacca et 
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al., 2007). Finally, the punctate pattern of hemin-, baicalein- or CdCl2-induced HO-1 
accumulation in A6 cells may be the result of HO-1 oligomerization. This possibility is based on 
studies that have shown that NADPH cytochrome P450 reductase can inhibit nuclear 
translocation and promote the formation of HO-1 into higher order complexes containing 
biliverdin reductase (Huber et al., 2009; Linnenbaum et al., 2012).   
The next phase of this study examined whether hemin, baicalein or CdCl2 treatment 
induced oxidative stress in A6 cells by examining the levels of PRDX5 and ROS. PRDX5 levels 
were detected constitutively in A6 kidney epithelial cells, which agrees with previous studies 
showing that the prdx5 gene was robustly expressed in the proto-nephric region in developing X. 
laevis embryos (Shafer et al., 2011). In A6 cells, hemin treatment enhanced PRDX5 
accumulation relative to control. Studies in mammalian systems indicated that the prdx5 gene 
promoter possesses a MARE sequence suggesting that its expression may occur by means of 
Bach1 repression as noted above (Nguyen-Nhu et al., 2007). In contrast to PRDX5, hemin 
treatment did not result in enhanced ROS levels compared to control. This latter finding was 
unusual, as free heme is generally thought to be a strong inducer of oxidative stress (Kumar and 
Bandyopadhyay, 2005). It is possible that this assay, which is designed for mammalian cells, may 
not be sensitive enough to detect hemin-induced ROS levels in Xenopus cells or that HO-1 
induction by hemin occurs at concentrations that are lower than those required to induce elevated 
levels of ROS. In contrast to hemin, baicalein enhanced ROS and PRDX5 levels compared to 
control. Prior studies have shown that 25 to 250 μM baicalein treatment can upregulate ROS 
levels in osteosarcoma, human leukemia, lung and bladder cancer cells (Wang et al., 2004; Ye et 
al., 2015; Kim et al., 2016; Choi et al., 2016). While baicalein is thought to function as an 
antioxidant molecule outside the cell, it was suggested that its ability to induce antioxidant 
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enzyme expression may partly be a consequence of it upsetting redox regulation in vivo in 
addition to its more direct effects on Nrf2 (Lin et al., 2007). Baicalein and CdCl2 treatment of A6 
cells also increased PRDX5 accumulation, likely due to their ability to stabilize Nrf2. Finally, 
CdCl2 treatment of A6 cells resulted in robust ROS levels compared to hemin or baicalein. In 
support of this finding, cadmium-induced ROS formation was detected in rat tissue lysates by 
means of spin-trapping and electron spin resonance studies (Liu et al., 2009). Furthermore, 
cadmium caused an increase in lipid peroxidation, an indicator of ROS activity, in R. decussatus 
gill tissue (Geret et al., 2002). ROS formation in response to cadmium was also reported in 
freshwater turtle plasma, mouse neurons and chicken testes (Song et al., 2017; Huo et al., 2018; 
Moyano et al., 2018). 
In experiments measuring oxidative stress using the CellRox detection assay, it was 
found that the highest level of ROS compared to control was generated by the positive control, 
BSO. BSO is an inhibitor of glutathione synthesis that was found to deplete glutathione in rat 
hepatocytes and X. laevis gametes (Kannan et al., 1996; Xu et al., 2003; Tong et al., 2015). Also, 
Xu et al. (2003) reported that CdCl2 treatment of rat hepatocytes depleted glutathione levels 
resulting in enhanced ROS levels. In the present study, while BSO supplementation did not 
augment hemin- or baicalein-induced HO-1 accumulation, BSO enhanced HO-1 accumulation in 
CdCl2-treated cells. In my research, SOD1 was also examined since its gene promoter contains a 
MARE element and previous studies reported that it was induced by cadmium exposure in rat 
hepatoma cells, zebrafish gills and mouse liver (Yoo et al., 1999; Liu et al., 2015; Yin et al., 
2018). In A6 cells, BSO alone induced SOD1 accumulation, as did hemin, baicalein and CdCl2 
while supplementation with BSO did not enhance stress-induced SOD1 levels. In a study 
examining the effects of cadmium and BSO in rat hepatocytes, it was noted that increases in the 
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expression of antioxidant genes caused by each of these agents, individually, were of comparable 
magnitude (Hsiao and Stapleton, 2009). It was suggested in this latter paper that both cadmium 
and BSO exerted their influence through glutathione depletion and the resultant activation of 
Nrf2. If this was the case in A6 cells then it suggests that ROS and Nrf2 activation, alone, were 
not sufficient for HO-1 induction since BSO induced SOD1 but not HO-1. Secondly, it suggested 
that the Nrf2 pathway that was activated by BSO was not further potentiated by hemin, baicalein 
or CdCl2, since SOD1 accumulation in response to these agents was not enhanced by BSO 
supplementation. Since CdCl2-induced HO-1 accumulation was enhanced by BSO, it indicates 
that HO-1 induction may not be mediated exclusively by Nrf2 and that another, as yet 
unidentified, pathway may be involved. Interestingly, it was reported that BSO enhanced the 
cadmium-induced accumulation of proteins important for proteostasis (Abe et al., 1994; Galan et 
al., 2001; Shirriff and Heikkila, 2017).  
Since CdCl2 treatment induced HO-1 accumulation, SnPP and ZnPP were used to 
determine if inhibition of HO-1 enzyme activity had an effect on HO-1 levels in A6 cells treated 
with 50 μM CdCl2. Immunoblot analysis determined that ZnPP weakly induced HO-1 levels 
compared to control or the positive control, hemin exposure. Also, SnPP did not induce 
significant levels of HO-1 accumulation. However, both inhibitors strongly enhanced CdCl2 
mediated accumulation of HO-1 as well as HSP70. Immunocytochemical analysis also showed 
that there was a strong enhancement in HO-1 staining in cells treated with SnPP or ZnPP and 
cadmium compared to those treated with cadmium alone. It was reported that HO-1 induction by 
metalloporphyrins is via activation of upstream MARE sites, suggesting involvement of the 
proteins of the Nrf2/Bach1 pathway (Kwok, 2013). However the weak induction of HO-1 by 
ZnPP and the lack of significant induction by SnPP, as well as the absence of detectable 
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induction of HSP70 by either of the enzyme activity inhibitors indicates that this mechanism may 
not be responsible for the enhancement of cadmium induced HO-1 and HSP70 accumulation. 
Alternatively, it could be an indication that HO-1 enzyme activity inhibition enhances the 
deleterious effects of cadmium treatment/stress. 
In order to observe the effects of HO-1 enzyme activity inhibitors on the morphology of 
cadmium-treated cells, immunocytochemical methods were used to monitor the actin 
cytoskeleton. Previous studies have shown that treatment of cells with CdCl2 or oxidative stress 
can cause actin fragmentation and depolymerisation (Huot et al., 1996; Wang et al., 1996; 
Woolfson and Heikkila, 2009) The disruption of the actin cytoskeleton by cadmium appears to be 
dependent on the action of gelsolin, which is thought to be activated as a consequence of 
apoptosis triggered by CdCl2 (Apostalova et al., 2005; Liu and Templeton, 2010). While the HO-
1 enzyme activity inhibitors or 100 μM CdCl2 had a control-like actin cytoskeleton, CdCl2 in 
combination with ZnPP and SnPP resulted in a severe disturbance of the actin cytoskeletal 
network. Disorganization of tubulin also occurred in cells treated with both cadmium and ZnPP 
or SnPP. This was possibly due to enhancement of cadmium-mediated damage to proteins or it 
may be a reflection of gross changes in cell morphology due to disruption of the cytoskeletal 
actin network (Galazyn-Sidorczuk et al., 2009; Tamás et al., 2014).  
Studies in our laboratory determined that treatment of A6 cells with CdCl2 induced the 
accumulation of aggregated protein and the formation of aggresome-like structures (Khan et al., 
2015; Shirriff and Heikkila, 2017). Since ZnPP and SnPP treatment each accentuated CdCl2-
induced actin cytoskeletal disruption of A6 cells, a Proteostat dye was employed to monitor the 
effect of these combined treatments on aggregated protein and aggresome-like structure 
formation. Interestingly, the HO-1 enzyme activity inhibitors increased the production of 
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aggregated protein and aggresome-like structures induced by CdCl2. These findings suggested 
that endogenous HO-1 enzyme activity may be required to mitigate the effects of CdCl2 toxicity. 
Suppression of HO-1 by these enzyme activity inhibitors was reported to enhance the toxic 
effects of cadmium in other cell types. For example, caspase-3 activity and ROS production in 
cadmium-treated liver cells were significantly enhanced by the addition of SnPP (Lawal et al., 
2015). In human renal tubule cells, SnPP-induced HO-1 enzyme activity inhibition suppressed 
hemin-mediated protection against cadmium damage (Yang et al., 2003). Additionally, the 
inhibition of HO-1 enzyme activity by ZnPP and/or SnPP was reported to enhance the toxicity of 
other stressors as well. For example, HO-1 enzyme activity inhibition by ZnPP enhanced the 
cytotoxicity of the chemotherapeutic agent, gemcitabine, in human prostate cells (Miyake et al., 
2010). Finally, both ZnPP and SnPP each enhanced colonic damage suffered by rats in response 
to trinitrobenzene treatment (Varga et al., 2007).  
In contrast to ZnPP and SnPP, HO-1 accumulation inducers, hemin and baicalein, were 
reported to protect animal model systems against oxidative stress and inflammatory tissue 
injuries (Yoneya et al., 2000; Chen et al., 2008; Liu et al., 2010; Jung and Lee, 2014; Choi et al., 
2016). For example, hemin conferred cytoprotection against hydrogen peroxide treatment of 
human tracheal epithelial cells, serum depletion of human monocytes and cold stress in human 
tubular epithelial cells (Yamada et al., 1998; Salahudeen et al., 2001; Lang et al, 2004). Also, 
baicalein treatment inhibited oxidative stress-induced apoptosis in rat glial cells, mouse 
macrophages and human melanocytes (Chen et al., 2006; Lin et al., 2007; Liu et al., 2012).  
However, there is very little information available on the possible cytoprotective effects of HO-1 
accumulation against potentially lethal concentrations of cadmium in animal cells. In the present 
study, treatment of A6 cells with 275 μM CdCl2 resulted in highly disorganized actin 
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cytoskeletons and irregular cell boundaries. However, treatment with hemin or baicalein 
mitigated the effects of CdCl2 on actin cytoskeletal structure. In previous studies, hemin 
treatment was shown to protect rats against cadmium-induced testicular damage (Fouad et al., 
2009). In this latter study, co-treatment of cells with the HO-1 enzyme activity inhibitor, SnPP, 
suppressed the protection conferred by hemin. This finding suggested that the cytoprotection 
conferred by hemin may be mediated by HO-1. This connection between HO-1 and 
cytoprotection against cadmium-induced damage was reported in rat glial cells in which HO-1, 
induced by NO, inhibited the toxic effects of CdCl2-induced oxidative stress (Srisook et al., 
2005). Previously, it was reported that cadmium-mediated disruption of actin stress fibres was a 
consequence of pro-apoptotic mechanisms mediated by p38 MAPK activation (Apostalova et al., 
2005; Liu and Templeton, 2010). Also, it was found that HO-1-mediated production of CO 
inhibited apoptosis, also through a p38 MAPK based mechanism (Brouard et al., 2000). Thus, it 
is possible that the pro-apoptotic effects of cadmium and the anti-apoptotic effects of CO 
production by HO-1 are integrated at the level of p38 MAPK phosphorylation.  
Incubation of A6 cells with 275 μM CdCl2 also induced the accumulation of aggregated 
protein and aggresome-like structures compared to control. However, cotreatment with hemin or 
baicalein resulted in fewer Proteostat dye and anti-HSP30 antibody stained aggresome-like 
structures compared to CdCl2 treatment alone. Furthermore, the addition of the HO-1 enzyme 
activity inhibitor, SnPP, suppressed the effect of hemin or baicalein treatment. This result 
suggested that HO-1 enzyme activity induced by hemin or baicalein may be involved in 
suppressing the proteotoxic stress exerted by CdCl2. As stated earlier, cadmium-induced protein 
unfolding was the result of oxidative stress and interaction of cadmium ions with the protein 
backbone and thiol-containing residues (Galazyn-Sidorczuk et al., 2009; Tamás et al., 2014). 
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Additionally, HO-1 enzyme activity may counteract cadmium-induced oxidative stress through 
the production of bilirubin. Bilirubin was reported to act directly as an antioxidant in human 
endothelial cells (Ziberna et al., 2015). Also, bilirubin was reported to reduce superoxide 
production in rat kidneys through its inhibitory action on NADPH oxidase (Fuji et al., 2010). 
Previous studies reported that hemin-induced HO-1 enzyme activity or HO-1 overexpression 
resulted in enhanced ferritin accumulation (Gonzales et al., 2002; Lanceta et al., 2013). While 
ferritin is an iron-binding protein, it can bind to other metal cations including cadmium 
(Hegenauer, 1979; Flora and Pauchari, 2010). Thus, excess ferritin may sequester cadmium and 
mitigate its effects on protein unfolding. Hemin and baicalein may also inhibit protein 
aggregation independent of HO-1 activation. Both hemin and baicalein were reported to inhibit 
protein aggregation directly. For example, hemin was shown to non-specifically inhibit in vitro 
amyloid fibril-type aggregation of a wide variety of proteins, including alpha-synuclein, alcohol 
dehydrogenase, catalase, gamma-s-crystallin and beta-amyloid as well as being capable of 
disaggregating pre-existing fibrils (Liu et al, 2014; Hayden et al., 2015; Sonavane et al., 2017). 
Baicalein was reported to have a similar activity with respect to inhibiting the aggregation of 
various proteins in vitro including alpha-synuclein, 1SS-alpha-lacalbumin and lysozyme (Zhu et 
al., 2004; Bomhoff et al., 2006; Kostka et al., 2007). Finally, it was found to reduce alpha-
synuclein fibril formation in mouse neuroblastoma cells (Jiang et al., 2010). Therefore, it is 
possible that hemin and baicalein may have a direct effect on inhibiting protein aggregation as 
well as an indirect effect by activating the expression of ho-1 genes.  
It has been noted that amphibians are well suited to serve as sentinel species in 
monitoring ecological health as they are particularly sensitive to a variety of toxicants including 
heavy metals and endocrine disruptors (Berzins and Bundy, 2002; Kloas and Lutz, 2006; 
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Burggren & Warburton, 2007). The present study has revealed a number of biomarkers including 
HO-1, HSPs and aggregated protein that accumulated in response to cadmium treatment. Other 
studies have also used the Xenopus system in a similar fashion to examine the effect of other 
environmental toxicants including perfluoroalkylated substances and dioxins (Lavine et al., 
2005; Gorrochategui et al., 2016). The use of the biomarkers, which was explored in the current 
study, may be of value to the analysis of the effects of toxicants on other poikilotherms. It is 
important to develop these types of biomarkers not only to monitor the health of ecosystems but 
also in enconomic ventures such as fish farming.  
In the present study, it was determined that Nrf2-regulated proteins, namely HO-1, 
PRDX5, and SOD1, displayed differential accumulation in A6 cells in response to treatments 
with different agents. It is likely that different sets of stress proteins accumulate in response to 
different stressors in spite of having similar regulatory elements. In the future, a more 
comprehensive understanding of stress pathways would allow for more accurate associations to 
be made between specific environmental stressors and the induction of specific stress proteins. 
Performing initial analyses in a model poikilothermic tissue culture system reduces the need to 
collect large numbers of animals, especially those from a vulnerable declining population. 
 
Future directions 
 Given the findings of this thesis, future studies could examine a number of possible 
mechanisms in more detail. For example, this research demonstrated that two HO-1-inducing 
agents, hemin and baicalein, conferred cytoprotection in A6 cells subjected to a potentially lethal 
concentration of CdCl2. Administration of the HO-1 enzyme activity inhibitor, SnPP, suppressed 
this cytoprotective effect. This suggested that cytoprotection was a consequence of HO-1 enzyme 
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activity. This finding should be verified by inhibiting HO-1 accumulation using either RNAi or 
antisense morpholino oligonucleotides (Xia et al., 2007; Tandon et al., 2012). Conversely, it 
would be of interest to determine whether HO-1 accumulation induced by overexpression of ho-
1 gene expression in transfected cells was capable of inducing cytoprotection against high 
concentrations of CdCl2. 
 The present study also demonstrated that HO-1 accumulation by hemin, baicalein or 
CdCl2 were inhibited by the HSF1 inhibitor, KNK437. In future, this analysis should directly 
inhibit HSF1 and/or HSF2 by means of RNAi or morpholino technology to determine if these 
transcription factors were involved in ho-1 gene expression. 
 This study suggested that HO-1 activity protected A6 cells against oxidative stress by 
producing bilirubin, which subsequently acted as an antioxidant molecule (Fuji et al., 2010; 
Ziberna et al., 2015). One of the interesting properties of bilirubin is its amphipathicity, having 
both hydrophilic and hydrophobic protein domains (Tazuma and Holzbach, 1986). While there 
are numerous cellular defences against oxidative stress (e.g. catalase, SOD enzymes, the 
glutathione system, thioredoxins, peroxiredoxins, etc.) few of them would be capable of acting 
directly in a lipid environment. Oxidative stress generally causes peroxidation of membrane 
lipids (Turrens et al., 2003). Bilirubin is one of a few antioxidant defence mechanisms that could 
function within a biological membrane. If this is the case, then it is possible that HO-1 inducers 
are more effective at inhibiting lipid peroxidation than other ROS scavenging agents. The 
effectiveness of hemin and baicalein at inhibiting lipid peroxidation could be compared to the 
ROS scavenger dimethylthiourea and polyethylene glycol-superoxide dismutase by using a 
malondialdehyde assay (Kinugawa et al., 2000; Grotto et al, 2009; Sun, 2010; Kim et al., 2015).  
 Finally, in addition to the prevention of oxidative stress, the enzyme activity of HO-1 
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may also be associated with the prevention of apoptosis in CdCl2-treated A6 cells. While the 
morphology of the actin cytoskeleton in cadmium-treated A6 cells was consistent with apoptotic 
cells. However, it was impossible to conclude whether there was an increase in apoptosis by 
phalloidin staining alone (Bottone et al., 2013). Therefore, it would be useful to determine the 
proportion of cadmium-treated A6 cells that underwent apoptosis compared to those which were 
supplemented with heme or baicalein. Numerous quantitative assays for detecting apoptosis exist 
including annexin V staining combined with flow cytometry or caspase activation assays 
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